IL6
Synonyms
B-cell stimulatory factor 2, Interferon beta-2, IL6, IFNB2, IL-6, Interleukin-6, Interleukin 6, Hybridoma Growth Factor, IFN-Beta-2, BSF-2, CDF, B-Cell Differentiation Factor, Interferon, Beta 2, Interleukin BSF-2, BSF2, HGF, HSF, CTL Differentiation Factor, Interleukin 6 (Interferon, Beta 2),Description
Interleukin-6 is an interleukin that acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine. In humans, it is encoded by the IL6 gene.Cytokine with a wide variety of biological functions in immunity, tissue regeneration, and metabolism. Binds to IL6R, then the complex associates to the signaling subunit IL6ST/gp130 to trigger the intracellular IL6-signaling pathway (Probable). The interaction with the membrane-bound IL6R and IL6ST stimulates 'classic signaling', whereas the binding of IL6 and soluble IL6R to IL6ST stimulates 'trans-signaling'. Alternatively, 'cluster signaling' occurs when membrane-bound IL6:IL6R complexes on transmitter cells activate IL6ST receptors on neighboring receiver cells (Probable).IL6 is a potent inducer of the acute phase response. Rapid production of IL6 contributes to host defense during infection and tissue injury, but excessive IL6 synthesis is involved in disease pathology. In the innate immune response, is synthesized by myeloid cells, such as macrophages and dendritic cells, upon recognition of pathogens through toll-like receptors (TLRs) at the site of infection or tissue injury (Probable). In the adaptive immune response, is required for the differentiation of B cells into immunoglobulin-secreting cells. Plays a major role in the differentiation of CD4 T cell subsets. Essential factor for the development of T follicular helper (Tfh) cells that are required for the induction of germinal-center formation. Required to drive naive CD4 T cells to the Th17 lineage. Also required for proliferation of myeloma cells and the survival of plasmablast cells.Acts as an essential factor in bone homeostasis and on vessels directly or indirectly by induction of VEGF, resulting in increased angiogenesis activity and vascular permeability . Induces, through 'trans-signaling' and synergistically with IL1B and TNF, the production of VEGF . Involved in metabolic controls, is discharged into the bloodstream after muscle contraction increasing lipolysis and improving insulin resistance . 'Trans-signaling' in central nervous system also regulates energy and glucose homeostasis. Mediates, through GLP-1, crosstalk between insulin-sensitive tissues, intestinal L cells and pancreatic islets to adapt to changes in insulin demand. Also acts as a myokine (Probable). Plays a protective role during liver injury, being required for maintenance of tissue regeneration. Also has a pivotal role in iron metabolism by regulating HAMP/hepcidin expression upon inflammation or bacterial infection . Through activation of IL6ST-YAP-NOTCH pathway, induces inflammation-induced epithelial regeneration.
KO Status
F1 (+/-)
Drug Information
Launched drugs: 18
Drugs in clinical trials: 5
Latest Research Phase:Approved
Drug Name
Code
Phase
Company
Indications
Clinical Trials
Luminol sodium
MP-1032
Approved
Selvim, Metrio
Immune System Diseases, Psoriasis
NCT Number
NCT02908347
NCT03706209
Intervention Type
Drug
Drug
Indications
Psoriasis; Plaque Psoriasis
Psoriasis
Study Phase
Phase 2
Phase 2
Recruitment Status
Completed
Completed
Thalidomide
K-17, NSC-66847, NSC-527179
Approved
Celgene
HIV Infections, Spondylitis, Ankylosing, Myelodysplastic Syndromes, Multiple Myeloma, HIV Wasting Syndrome, Erythema Nodosum, Leprosy, Lepromatous, Carcinoma, Hepatocellular
NCT Number
NCT02559154
NCT04612582
NCT02844361
NCT01664975
NCT01249690
NCT00314665
NCT02401971
NCT02844309
NCT01640639
NCT02778893
NCT01638078
NCT03122431
NCT00652041
NCT03777930
NCT00390247
NCT02858804
NCT00111319
NCT01659658
NCT01539083
NCT03402295
NCT00217438
NCT03221166
NCT00004859
NCT00910897
NCT01134484
NCT00432458
NCT00083551
NCT00225290
NCT00461747
NCT00038233
NCT03318835
NCT01070862
NCT00033332
NCT00028886
NCT00075829
NCT00734877
NCT00098475
NCT00572169
NCT00083915
NCT00644306
NCT00215943
NCT00097981
NCT00222053
NCT00061919
NCT00573391
NCT00443235
NCT02203253
NCT00207805
NCT00452569
NCT00041080
NCT00367185
NCT00416897
NCT00305552
NCT03016000
NCT00005966
NCT00529633
NCT02085655
NCT00633542
NCT00602511
NCT00892346
NCT00057564
NCT00507416
NCT00111748
NCT02248428
NCT00050843
NCT00083876
NCT00218855
NCT01063179
NCT02707484
NCT00600028
NCT02748772
NCT00921531
NCT00787436
NCT00033254
NCT00005834
NCT00720538
NCT01971658
NCT00232934
NCT01532856
NCT01554852
NCT00004635
NCT01858571
NCT00934154
NCT00049673
NCT00256776
NCT00205751
NCT02387086
NCT02532738
NCT01438450
NCT00934739
NCT00657488
NCT04453345
NCT00728078
NCT00038090
NCT01094340
NCT03062800
NCT00165451
NCT00320476
NCT00871013
NCT00053001
NCT00769587
NCT00747123
NCT02410694
NCT00053287
NCT00075023
NCT00450008
NCT00792142
NCT00379353
NCT01891019
NCT00319865
NCT00006358
NCT00400517
NCT00009984
NCT00040937
NCT00890188
NCT00089544
NCT03273452
NCT00226980
NCT00020046
NCT02447679
NCT00026533
NCT00287872
NCT00083382
NCT01849783
NCT02022033
NCT00201357
NCT00083408
NCT00039468
NCT00006226
NCT04680195
NCT00083005
NCT00001599
NCT00112502
NCT00003894
NCT02501291
NCT00054158
NCT01548573
NCT00577512
NCT03341494
NCT00521482
NCT00019747
NCT00378755
NCT00250796
NCT00017316
NCT00505635
NCT00104988
NCT00038181
NCT00015990
NCT00281827
NCT00165217
NCT03980002
NCT00151281
NCT00027664
NCT02891811
NCT00083577
NCT00019123
NCT00083681
NCT00025220
NCT02424851
NCT01632150
NCT01756989
NCT00114192
NCT00438841
NCT02995707
NCT00072345
NCT00047294
NCT00140452
NCT00003754
NCT00025467
NCT01551641
NCT04273581
NCT00033709
NCT00079092
NCT00019539
NCT00953615
NCT00049374
NCT00083902
NCT00209014
NCT00006016
NCT00284505
NCT02128230
NCT00227682
NCT00961467
NCT01779167
NCT00124813
NCT01526694
NCT00121563
NCT01114048
NCT03140943
NCT00008242
NCT00310076
NCT00349115
NCT00358020
NCT00025285
NCT00193544
NCT00003850
NCT00301405
NCT00445900
NCT01527032
NCT00090870
NCT00357500
NCT00276705
NCT00046826
NCT03043105
NCT00027638
NCT00412542
NCT03896737
NCT00006890
NCT00450801
NCT00307294
NCT02201043
NCT00538733
NCT00053430
NCT00182663
NCT00016224
NCT00455910
NCT00001680
NCT00142116
NCT03004287
NCT00469703
NCT03393273
NCT00004276
NCT04352205
NCT04120519
NCT00064337
NCT00276744
NCT03608501
NCT00002127
NCT00047879
NCT00112879
NCT00001524
NCT00006200
NCT02966522
NCT00238329
NCT00000790
NCT00389935
NCT00222105
NCT00964496
NCT02879526
NCT00083538
NCT00274820
NCT00231140
NCT00058487
NCT03069326
NCT00384800
NCT01125176
NCT01274403
NCT00006198
NCT00081939
NCT00869232
NCT00053300
NCT00958854
NCT01328236
NCT00083694
NCT00026416
NCT00004876
NCT00165230
NCT00015821
NCT00531453
NCT02586038
NCT00193102
NCT00089609
NCT00458705
NCT00025519
NCT00006006
NCT00049361
NCT00519688
NCT02733380
NCT00004088
NCT00251511
NCT00001446
NCT00179881
NCT00030550
NCT00777998
NCT01976195
NCT01485224
NCT00670631
NCT04382300
NCT00026520
NCT00083707
NCT00047281
NCT02649101
NCT00856804
NCT00162760
NCT00538824
NCT01341262
NCT01356290
NCT00022581
NCT02507336
NCT00723658
NCT03335098
NCT02754960
NCT00523848
NCT00025506
NCT00072163
NCT03208413
NCT02301949
NCT00577668
NCT03184844
NCT00113932
NCT01775553
NCT01055301
NCT00373646
NCT00006005
NCT04273529
NCT00098865
NCT00089167
NCT00124579
NCT00022607
NCT00015912
NCT00263484
NCT01242267
NCT00966693
NCT00155272
NCT00971126
NCT01057225
NCT00406978
NCT00277017
NCT02545907
NCT00005815
NCT00081757
NCT01061866
NCT00096018
NCT02145715
NCT00038246
NCT01661400
NCT00083460
NCT00014443
NCT00000812
NCT01420432
NCT00052416
NCT00002104
NCT02467647
NCT00251797
NCT00049296
NCT02870036
NCT01998971
NCT00062127
NCT01937442
NCT00258245
NCT00418132
NCT00527657
NCT01028781
NCT02956538
NCT01537861
NCT00577096
NCT00907452
NCT00002157
NCT00002174
NCT02998827
NCT01697839
NCT01927718
NCT00002392
NCT01924624
NCT00899080
NCT00004450
NCT03601871
NCT01268774
NCT02293681
NCT00023530
NCT03723083
NCT03089411
Intervention Type
Drug
Drug
Other
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug;Genetic
Drug
Radiation;Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Procedure;Drug;Behavioral
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure
Drug
Other;Drug
Drug
Procedure;Drug
Drug
Other;Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Procedure
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Radiation;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other;Procedure;Drug;Genetic
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Procedure;Biological;Drug
Drug
Procedure;Other;Radiation;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Procedure;Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Procedure;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Procedure;Drug
Drug
Biological;Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Biological;Drug
Procedure;Biological;Drug
Drug
Drug
Biological;Drug
Procedure;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Procedure;Drug
Drug
Drug
Procedure;Drug
Other;Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Other;Biological;Drug;Genetic
Drug
Procedure;Biological;Radiation;Drug
Biological;Drug
Radiation;Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Drug
Procedure;Drug
Drug
Procedure
Drug
Drug
Combination Product
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Procedure;Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Drug
Procedure
Drug
Other;Procedure;Drug;Genetic
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Drug
Drug
Biological;Drug;Behavioral
Drug
Drug
Drug
Other;Drug
Drug;Behavioral
Drug
Drug
Other;Genetic
Drug
Drug
Drug
Procedure;Drug
Drug
Indications
Multiple Myeloma
Immunoglobulin Light-Chain Amyloidosis
Waldenström Macroglobulinemia
Peripheral T-cell Lymphoma
Multiple Myeloma
Uveitis
Gastric Cancer
Waldenström Macroglobulinemia
Congestive Heart Failure
NSCLC
Coronary Artery Disease
Systemic Lupus Erythematosus (SLE); Juvenile SLE; Cutaneous Lupus
Multiple Myeloma
Cancer, Therapy-Related
Peritoneal Dialysis; Malnutrition
Mantle Cell Lymphoma
Multiple Myeloma
Relapsed or Refractory Systemic Light Chain Amyloidosis
Multiple Myeloma
Multiple Myeloma; Effects of Chemotherapy
Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Crohn Disease
Lung Cancer
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Carcinoma, Hepatocellular
Multiple Myeloma
Multiple Myeloma
Thalidomide
Multiple Myeloma de Novo Treatment
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Newly Diagnosed, Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lung Cancer
Multiple Myeloma
Multiple Myeloma
Neoplasms
Multiple Myeloma
Multiple Myeloma
Fallopian Tube Cancer; Primary Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm; Renal Failure
Sarcoidosis
Lymphoma, Large B-Cell, Diffuse
Kidney Cancer
Hypoalbuminemia
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Gastrointestinal Vascular Malformation
Idiopathic Pulmonary Fibrosis; Cough
Colorectal Neoplasms
Hepatocellular Carcinoma
Gastrointestinal Hemorrhage; Portal Hypertension
Tumors Metastatic to Brain
Multiple Myeloma
Inflammatory Bowel Diseases; Crohn's Disease; Ulcerative Colitis
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Prostate Cancer
Malignant Childhood Neoplasm
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
NSCLC
Crohn's Disease
Hepatocellular Carcinoma
Oral Cavity Cancer
Multiple Myeloma
T-LGL Leukemia; Clpd-Nk
Hepatocellular Carcinoma; Liver Cancer
Multiple Myeloma
Alzheimer's Disease
Advanced Nsclc
Neoplasms
Multiple Myeloma
Myeloma
Anemia; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Non Neoplastic Condition; Precancerous Condition
Multiple Myeloma
Multiple Myeloma
Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Graft-versus-Host Disease; Stomatitis
Prostatic Neoplasms
Multiple Myeloma and Plasma Cell Neoplasm; Neurotoxicity
Advanced Cancers
Psoriasis, Plaque-type
Multiple Myeloma
Brain and Central Nervous System Tumors
Prostate Cancer
Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia
Multiple Myeloma
Colon Cancer
Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma AJCC v7; Stage II Adult Soft Tissue Sarcoma AJCC v7; Stage III Adult Soft Tissue Sarcoma AJCC v7
Angioimmunoblastic T-cell Lymphoma
Kidney Neoplasms
Stage IV Prostate Cancer; Adenocarcinoma of the Prostate; Recurrent Prostate Cancer
Adult Hepatocellular Carcinoma; Recurrent Hepatocellular Carcinoma; Adverse Reaction to Drug; Vascular Endothelial Growth Factor Overexpression
Head and Neck Cancer
Multiple Myeloma
Multiple Myeloma
Extramedullary Plasmacytoma; Isolated Plasmacytoma of Bone; Light Chain Deposition Disease; Primary Systemic Amyloidosis; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Pancreatic Cancer
Hormone-refractory Prostate Cancer
Multiple Myeloma
Brain and Central Nervous System Tumors
B-cell Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia
Chronic Radiation Proctitis
Prostate Cancer
Sjogren's Syndrome; Xerostomia
Brain and Central Nervous System Tumors
Graft Versus Host Disease; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Crohn's Disease
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
NSCLC Stage IV; Chemotherapy Effect
Glioblastoma
Colorectal Cancer
Multiple Myeloma
Liver; Cancer
Melanoma (Skin)
Melanoma
Melanoma (Skin)
Prostate Cancer
Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Ringed Sideroblasts; Secondary Myelodysplastic Syndromes
Lung Cancer
Colorectal Adenocarcinoma
Chronic Lymphocytic Leukemia
Non-Hodgkin's Lymphoma
Kidney Cancer
Multiple Myeloma
Multiple Myeloma
Sarcoma
Multiple Myeloma
Recurrent Uterine Corpus Sarcoma; Uterine Corpus Leiomyosarcoma
Multiple Myeloma; Chronic Kidney Disease
Relapsed and/or Refractory Multiple Myeloma
Brainstem Glioma
Lung Cancer
Multiple Myeloma and Plasma Cell Neoplasm
Thalassemia
Intraocular Melanoma; Melanoma (Skin)
Brain and Central Nervous System Tumors
Amyotrophic Lateral Sclerosis; ALS
Unspecified Childhood Solid Tumor, Protocol Specific
Endometrial Adenoacanthoma; Endometrial Adenocarcinoma; Endometrial Adenosquamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Endometrial Papillary Serous Carcinoma; Recurrent Endometrial Carcinoma
Esophageal Cancer
COVID-19 Thalidomide
Sarcoma
Brain and Central Nervous System Tumors
Stage IV Renal Cell Cancer; Recurrent Renal Cell Cancer
Primary Sclerosing Cholangitis
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
B-Cell Lymphoma; Hodgkin's Disease
Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer
Arachnoiditis
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Waldenstrom Macroglobulinemia
Multiple Myeloma
Multiple Myeloma
Pain
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Carcinoma of the Appendix; Colorectal Cancer
Multiple Myeloma
Multiple Myeloma
Lung Cancer
Multiple Myeloma
Head and Neck Cancer
Chronic Prostatitis; Pelvic Pain
Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
Amyloidosis
Kidney Cancer
Central Nervous System Tumor, Pediatric; Leukemia; Lymphoma; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
Liver Cancer
Prostate Cancer
Multicentric Castleman Disease
Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Lung Cancer; Neoplastic Syndrome
Glioblastoma Multiforme; Glioma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Lymphoma
Prostate Cancer
Ankylosing Spondylitis
Multiple Myeloma
HIV Infections
Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Ovarian Cancer
Myelodysplastic Syndromes
Discoid Lupus Erythematosus
Waldenstrom's Macroglobulinemia; Lymphoplasmacytic Lymphoma
Multiple Myeloma
Chronic Pancreatitis
Multiple Myeloma
HIV Infections; Mycobacterium Infections; Tuberculosis
Plasma Cell Myeloma; Renal Failure
Langerhans Cell Histiocytosis
Multiple Myeloma; Plasma Cell Myeloma
Pancreatic Cancer
Multiple Myeloma
HIV Infections; HIV Wasting Syndrome
Glioma
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
Acquired Immunodeficiency Syndrome; Burning Mouth Syndrome; HIV Infection
Melanoma
Cardiac Amyloidosis
Intraocular Melanoma; Melanoma (Skin)
HIV Infections; Stomatitis, Aphthous
Arteriovenous Malformation; Hereditary Hemorrhagic Telangiectasia; Hematochezia; Melena
Multiple Myeloma
Obscure Gastrointestinal Bleeding; Angiodysplasia; Gastric Antral Vascular Ectasia; Thalidomide
Relapse/Refratory Peripheral T Cell Lymphoma
Multiple Myeloma
Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Amyotrophic Lateral Sclerosis (ALS)
Liver Cancer
Myelofibrosis
Carcinoma, Hepatocellular
Chronic Lymphocytic Leukemia
Multiple Myeloma
Liver Cancer
Multiple Myeloma
Multiple Myeloma
Lung Cancer
Lymphoma
Plasma Cell Leukemia; Multiple Myeloma
Leukemia
Sarcoma
Ovarian Cancer
Neuroendocrine Tumor
Primary Myelofibrosis
Multiple Myeloma
Multiple Myeloma
Breast Cancer
Prostatic Neoplasms
Multiple Myeloma and Plasma Cell Neoplasm
Kidney Cancer
Liver Cancer
Brain and Central Nervous System Tumors; Unspecified Adult Solid Tumor, Protocol Specific
Hepatocellular Carcinoma
Diffuse Large B-cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndrome
Prostatic Neoplasm
Brain Stem Neoplasms, Primary; Neoplasms, Brain Stem
Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
Multiple Myeloma
Immune Thrombocytopenia
Hereditary Hemorrhagic Telangiectasia; Epistaxis
Multiple Myeloma
Non-small Cell Lung Cancer
Melanoma (Skin)
Waldenstrom Macroglobulinemia
Brain and Central Nervous System Tumors
Metastatic Breast Cancer
Hepatitis C
Idiopathic Pulmonary Fibrosis (IPF)
Multiple Myeloma
Multiple Myeloma
Medulloblastoma Recurrent; Ependymoma Recurrent; ATRT Recurrent
Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Small Lymphocytic Lymphoma
Mantle Cell Lymphoma; Non-Hodgkin's Lymphoma
Lymphoma
Waldenstrom Macroglobulinemia; Lymphoplasmacytic Lymphoma
Gastrointestinal Hemorrhage; Vascular Malformation
Multiple Myeloma and Plasma Cell Neoplasm
Recurrent Uterine Corpus Sarcoma; Uterine Carcinosarcoma
Recurrent Melanoma; Stage IV Melanoma; Tumors Metastatic to Brain
Radiation Injuries
Gastrointestinal Bleeding of Unknown Origin; Gastrointestinal Vascular Malformation; Thalidomide Efficiency
Multiple Myeloma
Thalassemia
Multiple Myeloma
Relapse Multiple Myeloma; Refractory Multiple Myeloma
Multiple Myeloma; Plasma Cell Myeloma
MALT Lymphoma
Endometrial Cancer; Sarcoma
COVID-19 Thalidomide
Central Nervous System Tumor, Pediatric; Neuroblastoma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma
Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Hepatocellular Carcinoma
Hepatocellular Carcinoma
Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Multiple Myeloma
Kidney; Cancer
Amyloidosis
Intraocular Melanoma; Melanoma (Skin)
Multiple Myeloma
Refractory Epilepsy
Leukemia
Multiple Myeloma
Prostate Cancer
Glioma; Neuroectodermal Tumors, Primitive; Wilms Tumor; Rhabdomyosarcoma; Sarcoma, Ewing; Osteosarcoma; Retinoblastoma
Multiple Myeloma
Brain and Central Nervous System Tumors
HIV Infections
Ankylosing Spondylitis
Leukemia; Lymphoma
Mycobacterium Avium-Intracellulare Infection; HIV Infections; Tuberculosis, Mycobacterium Infection
Multiple Myeloma
Brain and Nervous System; Cancer
Cancer
Advanced Solid Tumor; Advanced/Metastatic Colorectal Cancer
Multiple Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Scleroderma, Systemic
Brain Neoplasms; Melanoma
Endometriosis
Crohn Disease
Multiple Myeloma
Multiple Myeloma
Myeloma
HIV Infections; HIV Wasting Syndrome
HIV Infections
Crohn Disease
Multiple Myeloma; Peripheral Neuropathy
Myeloma
HIV Infections
Hepatocellular Carcinoma; Recurrence
Multiple Myeloma and Plasma Cell Neoplasm
Adrenoleukodystrophy
Chemotherapy-induced Nausea and Vomiting
Multiple Myeloma
Spondylitis, Ankylosing
Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Graft vs Host Disease
Dermatologic; Other
Myeloma Multiple
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Unknown status
Recruiting
Unknown status
Completed
Unknown status
Terminated
Unknown status
Unknown status
Unknown status
Unknown status
Unknown status
Recruiting
Completed
Not yet recruiting
Withdrawn
Unknown status
Completed
Active, not recruiting
Completed
Completed
Completed
Terminated
Terminated
Unknown status
Unknown status
Completed
Completed
Terminated
Completed
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Terminated
Terminated
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Terminated
Active, not recruiting
Completed
Completed
Suspended
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Recruiting
Completed
Unknown status
Unknown status
Withdrawn
Completed
Terminated
Completed
Completed
Completed
Unknown status
Active, not recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Unknown status
Unknown status
Unknown status
Terminated
Completed
Recruiting
Unknown status
Completed
Unknown status
Recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Terminated
Terminated
Completed
Completed
Completed
Unknown status
Completed
Completed
Terminated
Completed
Unknown status
Terminated
Unknown status
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Recruiting
Unknown status
Terminated
Unknown status
Completed
Completed
Terminated
Completed
Completed
Completed
Terminated
Completed
Recruiting
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Completed
Unknown status
Not yet recruiting
Unknown status
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Completed
Active, not recruiting
Terminated
Completed
Terminated
Unknown status
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Unknown status
Completed
Active, not recruiting
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Terminated
Withdrawn
Completed
Recruiting
Recruiting
Completed
Terminated
Withdrawn
Completed
Completed
Withdrawn
Completed
Unknown status
Unknown status
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Terminated
Completed
Recruiting
Unknown status
Active, not recruiting
Completed
Unknown status
Completed
Active, not recruiting
Completed
Unknown status
Unknown status
Completed
Unknown status
Completed
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Completed
Withdrawn
Completed
Completed
Completed
Recruiting
Completed
Terminated
Completed
Completed
Completed
Unknown status
Withdrawn
Completed
Completed
Not yet recruiting
Completed
Completed
Completed
Unknown status
Unknown status
Completed
Terminated
Completed
Recruiting
Completed
Active, not recruiting
Withdrawn
Recruiting
Withdrawn
Completed
Completed
Completed
Recruiting
Withdrawn
Withdrawn
Unknown status
Completed
Completed
Withdrawn
Completed
Completed
Not yet recruiting
Completed
Completed
Terminated
Completed
Terminated
Completed
Completed
Completed
Unknown status
Terminated
Completed
Completed
Completed
Unknown status
Completed
Completed
Completed
Completed
Unknown status
Completed
Recruiting
Completed
Unknown status
Completed
Unknown status
Completed
Completed
Unknown status
Completed
Completed
Recruiting
Active, not recruiting
Completed
Completed
Completed
Terminated
Completed
Terminated
Unknown status
Terminated
Completed
Completed
Completed
Completed
Unknown status
Completed
Terminated
Completed
Unknown status
Completed
Completed
Recruiting
Completed
Terminated
Completed
No longer available
Unknown status
NED-260
NED-260
Preclinical
Ned Biosystems
Coronavirus Disease 2019 (COVID-19)
Mycobacterium cell wall-DNA Complex (ProMetic Life Sciences)
EN-3348
NDA/BLA
Prometic Life Sciences
Neoplasm Recurrence, Local, Urinary Bladder Neoplasms, Carcinoma in Situ
NCT Number
NCT01200992
NCT00406068
Intervention Type
Biological
Drug
Indications
Bladder Neoplasm; Neoplasm Recurrence, Local; Transitional Cell, Carcinoma; Carcinoma in Situ; Mycobacterium
Bladder Neoplasms
Study Phase
Phase 3
Phase 2/Phase 3
Recruitment Status
Terminated
Completed
Siltuximab
cCLB-8, CNTO-328
Approved
Eusa Pharma, Janssen Global Services Llc
Head and Neck Neoplasms, Ovarian Neoplasms, Respiratory Tract Infections, Carcinoma, Renal Cell, Pneumonia, Smoldering Multiple Myeloma, Pancreatic Neoplasms, Myelodysplastic Syndromes, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Lung Diseases, Respiratory Distress Syndrome, Adult, Multicentric Castleman's Disease (MCD), Prostatic Neoplasms, Neoplasms, Plasma Cell, Colorectal Neoplasms, Castleman Disease, Lung Neoplasms, Lymphoma, Non-Hodgkin
NCT Number
NCT04330638
NCT04616586
NCT00433446
NCT01024036
NCT04329650
NCT03315026
NCT00385827
NCT01400503
NCT01484275
NCT01513317
NCT00402181
NCT00401843
NCT00311545
NCT01531998
NCT04191421
NCT00265135
NCT02796859
NCT00841191
NCT00401765
NCT01219010
NCT01309412
NCT00412321
NCT02074800
NCT02805868
NCT02641522
NCT04486521
Intervention Type
Other;Drug
Other;Drug
Biological
Drug
Drug
Drug;Behavioral
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Biological
Drug;Behavioral
Biological
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Procedure;Other;Biological
Drug
Drug
Indications
COVID-19
Acute Respiratory Distress Syndrome; Lung Diseases; Pneumonia; Respiratory Tract Infections; Respiratory Tract Disease
Prostate Cancer
Multicentric Castleman's Disease
COVID-19
Multiple Myeloma; AL Amyloidosis
Cancer, Prostate
Multicentric Castleman's Disease
High-risk Smoldering Multiple Myeloma
Myelodysplastic Syndrome
Multiple Myeloma
Multiple Myeloma
Kidney Cancer
Myeloma
Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8
Carcinoma, Renal Cell
Schizophrenia; Psychotic Disorders
Ovarian Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Lung Neoplasms
Prostatic Neoplasms
Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Plasma Cell Neoplasm
Multiple Myeloma
Lymphoma, Non-Hodgkin; Multiple Myeloma; Giant Lymph Node Hyperplasia
Healthy
Myelofibrosis; Polycythemia Vera; Primary Myelofibrosis; Thrombocytopenia
Type 1 Diabetes
Critical Illness; Corona Virus Infection; Cytokine Release Syndrome
Study Phase
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
N/A
Recruitment Status
Active, not recruiting
Not yet recruiting
Completed
Completed
Recruiting
Active, not recruiting
Terminated
Completed
Completed
Terminated
Completed
Completed
Withdrawn
Completed
Recruiting
Completed
Recruiting
Completed
Completed
Completed
Terminated
Completed
Completed
Withdrawn
Completed
Recruiting
Lenalidomide
IMiD-3, CC-5013, CDC-501, CDC-5013, ENMD-0997, IMID-5013
Approved
Celgene Corp
Lymphoma, B-Cell, Marginal Zone, Recurrence, Hematologic Diseases, Leukemia, Myeloid, Lymphoma, B-Cell, HIV Infections, Lymphoma, T-Cell, Peripheral, Anemia, Paraproteinemias, Blood Protein Disorders, Myelodysplastic Syndromes, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, Large B-Cell, Diffuse, Smoldering Multiple Myeloma, Multiple Myeloma, Lymphoma, Follicular, Lymphoma, Mantle-Cell, Radiculopathy, Prostatic Neoplasms, Reflex Sympathetic Dystrophy, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Waldenstrom Macroglobulinemia, Thrombocytopenia, Leukemia, Myeloid, Acute, Neoplasm Metastasis, Melanoma, Leukemia, Lymphocytic, Chronic, B-Cell, Carcinoma, Non-Small-Cell Lung, Crohn Disease, Complex Regional Pain Syndromes
NCT Number
NCT01198054
NCT03416374
NCT03934684
NCT01731886
NCT04152577
NCT04038411
NCT03908138
NCT04348006
NCT01408199
NCT04361643
NCT04040491
NCT03173092
NCT04217967
NCT03829371
NCT02076009
NCT02112175
NCT04680052
NCT02659293
NCT03729804
NCT00111319
NCT02252172
NCT04071457
NCT02215980
NCT02579863
NCT00114101
NCT01650701
NCT00843882
NCT03941860
NCT01239797
NCT03617731
NCT03720041
NCT04084626
NCT03859427
NCT00988208
NCT04224493
NCT01335399
NCT03948035
NCT01208766
NCT04270409
NCT00179647
NCT01021423
NCT00179621
NCT01564537
NCT00522392
NCT04287660
NCT03652064
NCT02128061
NCT01208662
NCT01916252
NCT02544308
NCT02516423
NCT01554852
NCT02495922
NCT00166452
NCT01243944
NCT01476787
NCT00093028
NCT01530594
NCT00480363
NCT01091831
NCT01191060
NCT00478777
NCT00056160
NCT01093196
NCT00420849
NCT04096066
NCT01080391
NCT00424047
NCT00572169
NCT00689936
NCT02575144
NCT01122472
NCT00551928
NCT03651128
NCT03993912
NCT04288765
NCT00405756
NCT02354313
NCT03937635
NCT03901963
NCT03319667
NCT04483739
NCT04298372
NCT00928486
NCT01659658
NCT01863550
NCT01109004
NCT00644228
NCT01850524
NCT01621672
NCT01685814
NCT01243476
NCT00064038
NCT01996865
NCT00602641
NCT01029262
NCT02516696
NCT00774345
NCT00891384
NCT01169337
NCT02406144
NCT02285062
NCT02322320
NCT00098475
NCT01098656
NCT00622336
NCT04404283
NCT03710603
NCT01891643
NCT01938001
NCT02155634
NCT04566328
NCT00057616
NCT00430365
NCT03952091
NCT00910910
NCT01865110
NCT04490707
NCT00055562
NCT00120120
NCT02419118
NCT03428373
NCT01197560
NCT02145598
NCT02633137
NCT02219178
NCT00179686
NCT00675441
NCT00883623
NCT00759603
NCT01936532
NCT01036399
NCT00628238
NCT01415752
NCT00786851
NCT01393756
NCT00812968
NCT02928419
NCT01553149
NCT00067743
NCT01496976
NCT00109005
NCT01241786
NCT00535873
NCT03333746
NCT04032626
NCT00403169
NCT02897830
NCT01206205
NCT01459211
NCT01617213
NCT02272803
NCT03000634
NCT02720510
NCT02471820
NCT02619682
NCT04329130
NCT02294357
NCT01199575
NCT00695786
NCT01782963
NCT00065156
NCT03490344
NCT04063189
NCT00466921
NCT02060656
NCT00445692
NCT00267059
NCT01402284
NCT00238238
NCT02188368
NCT02871219
NCT01830478
NCT02802943
NCT03837873
NCT01939327
NCT00538733
NCT00848328
NCT00378209
NCT04174196
NCT00925821
NCT01858558
NCT03605056
NCT02420860
NCT01647165
NCT01556477
NCT01472562
NCT03367143
NCT01718379
NCT02523040
NCT01133275
NCT00874978
NCT03004287
NCT03376477
NCT03289299
NCT03669445
NCT03054532
NCT04480099
NCT00305812
NCT00742560
NCT02460276
NCT00091260
NCT02538965
NCT03544281
NCT02232516
NCT01133665
NCT02874742
NCT03003520
NCT00602836
NCT04094142
NCT01919619
NCT00996931
NCT01374217
NCT00907348
NCT00717756
NCT00963105
NCT00179673
NCT01401322
NCT04268498
NCT03188172
NCT00899431
NCT02389517
NCT01216683
NCT02986451
NCT03168100
NCT00691704
NCT01548573
NCT04129710
NCT01919086
NCT03673826
NCT01729091
NCT02880228
NCT02371590
NCT00482911
NCT01270932
NCT02193698
NCT00227591
NCT00840827
NCT01772420
NCT01379274
NCT00744536
NCT03290950
NCT01481194
NCT01351896
NCT01271283
NCT03412565
NCT04009109
NCT02371577
NCT02955823
NCT00352794
NCT01754870
NCT00546897
NCT01572480
NCT02309515
NCT01269203
NCT01032291
NCT03730740
NCT02126553
NCT00684242
NCT01675141
NCT01215344
NCT03477539
NCT01358734
NCT01054144
NCT03012880
NCT03641456
NCT01559935
NCT01779167
NCT00617591
NCT04025593
NCT02253316
NCT00096525
NCT00474188
NCT01133743
NCT00287287
NCT00619684
NCT02538198
NCT00607581
NCT03785184
NCT01702831
NCT04622579
NCT03411031
NCT00977132
NCT01553357
NCT03031483
NCT00833534
NCT00974233
NCT03697356
NCT04544059
NCT01342692
NCT02843074
NCT01924169
NCT01375140
NCT01611259
NCT02446457
NCT01816620
NCT04518982
NCT01194791
NCT04140162
NCT01178814
NCT02225275
NCT04460248
NCT02719613
NCT01442714
NCT01754857
NCT01723839
NCT00885508
NCT02331368
NCT01556035
NCT01307605
NCT00860457
NCT02903381
NCT01701076
NCT02441686
NCT00179660
NCT04404088
NCT00166413
NCT00478218
NCT01501370
NCT00961467
NCT00445484
NCT02532257
NCT02765854
NCT01775553
NCT01301820
NCT01518465
NCT01737177
NCT01055301
NCT03556332
NCT01127542
NCT01246076
NCT01724177
NCT00179738
NCT01816971
NCT01553786
NCT00418665
NCT01545804
NCT03269669
NCT04214626
NCT02917941
NCT00478959
NCT01116193
NCT00410605
NCT01673308
NCT01956695
NCT00087672
NCT04497961
NCT00360672
NCT00074282
NCT03495960
NCT00772915
NCT01282047
NCT00439231
NCT03212807
NCT04481815
NCT01419795
NCT04635189
NCT00424229
NCT00044382
NCT03409432
NCT00843310
NCT00142168
NCT02728102
NCT03959358
NCT03224507
NCT03815279
NCT01121757
NCT00867308
NCT04627753
NCT02906332
NCT03118466
NCT00352365
NCT01460940
NCT00847639
NCT00446433
NCT01011894
NCT00540007
NCT02636322
NCT00908232
NCT01160107
NCT01373294
NCT02005289
NCT00784927
NCT00779922
NCT01522976
NCT00322985
NCT00540644
NCT01380106
NCT04151667
NCT00765245
NCT00761449
NCT00957385
NCT01264315
NCT00751296
NCT01743859
NCT02353468
NCT03715309
NCT02472691
NCT01600053
NCT00044018
NCT01349569
NCT00923663
NCT03891355
NCT01132989
NCT00602459
NCT01316523
NCT00783367
NCT00567229
NCT01465230
NCT00799513
NCT01729338
NCT04352205
NCT00737529
NCT01160484
NCT04430894
NCT02128230
NCT01651039
NCT03232307
NCT03606577
NCT03809780
NCT01463670
NCT02399085
NCT00875667
NCT00902915
NCT01123356
NCT03252600
NCT01053806
NCT00109772
NCT02916771
NCT02969837
NCT04052880
NCT03863184
NCT00051116
NCT00654186
NCT01002755
NCT02415413
NCT02405364
NCT02086552
NCT00942578
NCT04277845
NCT00460031
NCT03733691
NCT01794039
NCT01450215
NCT01237249
NCT00720850
NCT00665652
NCT03746223
NCT01446133
NCT00679367
NCT00538824
NCT00655668
NCT00807599
NCT00482261
NCT01245673
NCT01307592
NCT01698801
NCT02203643
NCT02041325
NCT01639898
NCT01125176
NCT00064974
NCT00968331
NCT00553644
NCT00165477
NCT01088373
NCT03949062
NCT01497496
NCT00151203
NCT03019640
NCT00632359
NCT01706666
NCT03314636
NCT00837031
NCT01856192
NCT00564889
NCT03376672
NCT02206503
NCT02159365
NCT00609869
NCT04231370
NCT00065351
NCT01145495
NCT03104842
NCT01274533
NCT00971685
NCT00096044
NCT04223661
NCT04065789
NCT01593410
NCT02279394
NCT01718743
NCT01222195
NCT03184194
NCT02921893
NCT03500445
NCT02375555
NCT04002401
NCT00413036
NCT03413800
NCT01081431
NCT02348528
NCT00112827
NCT01079936
NCT02213913
NCT01038635
NCT02937571
NCT01002703
NCT02802163
NCT02343042
NCT01111903
NCT00396045
NCT00778752
NCT02180711
NCT02057640
NCT01303965
NCT02898259
NCT02561273
NCT02911142
NCT02733042
NCT02589145
NCT02631577
NCT02206425
NCT02075021
NCT03015792
NCT01368757
NCT01421186
NCT01057121
NCT00829647
NCT02983097
NCT01995669
NCT01412307
NCT01155583
NCT02963610
NCT01582776
NCT00699842
NCT01355705
NCT01638936
NCT02685826
NCT04539236
NCT01054196
NCT02529852
NCT00348595
NCT00975806
NCT00890929
NCT01583283
NCT04423926
NCT01060384
NCT01383928
NCT00294632
NCT02302469
NCT00507442
NCT03191981
NCT01788189
NCT00972842
NCT00831766
NCT01016600
NCT01531998
NCT00915408
NCT03980171
NCT01003769
NCT00352001
NCT02875067
NCT00670358
NCT00477750
NCT04257448
NCT01208051
NCT04607772
NCT00179751
NCT02281279
NCT01547260
NCT01019174
NCT04446962
NCT00901615
NCT01035463
NCT04663347
NCT01127386
NCT03011814
NCT02038153
NCT01703364
NCT02077166
NCT00966693
NCT00981708
NCT03100877
NCT00738829
NCT01241734
NCT01217957
NCT01049945
NCT02142049
NCT01348919
NCT00790842
NCT02341014
NCT04432714
NCT00621400
NCT01502085
NCT00378105
NCT01403246
NCT01076543
NCT01166035
NCT02077959
NCT00963534
NCT00179712
NCT01297764
NCT01029054
NCT00536341
NCT01615029
NCT01755975
NCT00306813
NCT02389543
NCT00910858
NCT01246557
NCT01668719
NCT02340936
NCT04120350
NCT00633594
NCT00727415
NCT01075321
NCT01180569
NCT01484626
NCT00939510
NCT01744912
NCT01010243
NCT02628405
NCT03015896
NCT01575860
NCT00987493
NCT01704781
NCT01342172
NCT01558167
NCT01142232
NCT00903630
NCT00724568
NCT01881789
NCT01093183
NCT00179725
NCT01686386
NCT02265510
NCT01460420
NCT01555281
NCT01352338
NCT01750983
NCT00840931
NCT01056679
NCT00398515
NCT00560391
NCT03150316
NCT01429025
NCT00031941
NCT01711671
NCT00884546
NCT04661007
NCT00923234
NCT01718899
NCT01644799
NCT01246622
NCT00933426
NCT02481934
NCT02335983
NCT00525447
NCT00412581
NCT01998971
NCT01578954
NCT01604031
NCT01965353
NCT01202890
NCT02426723
NCT00100880
NCT03591744
NCT01766583
NCT01542918
NCT00735930
NCT03373305
NCT01038388
NCT01954784
NCT01042704
NCT01732861
NCT01829568
NCT01629082
NCT00687674
NCT02721043
NCT03302728
NCT01681537
NCT01955499
NCT01886859
NCT00091624
NCT04196491
NCT01200004
NCT03984097
NCT01645930
NCT03208218
NCT01729104
NCT01904643
NCT02018523
NCT00153933
NCT03283046
NCT04519476
NCT03523975
NCT00502112
NCT01615042
NCT00642954
NCT00729638
NCT02160015
NCT02036502
NCT02312102
NCT00495872
NCT01749969
NCT01373229
NCT00415064
NCT01005979
NCT02334865
NCT03070327
NCT01562405
NCT00543114
NCT03701711
NCT03223610
NCT01218555
NCT02568553
NCT00864942
NCT04091126
NCT01045928
NCT04447716
NCT01088048
NCT04134936
NCT02521714
NCT04447027
NCT04609046
NCT04635683
NCT01985477
NCT04246086
NCT00580242
NCT01421927
NCT01619761
NCT02431208
NCT03015922
NCT02705638
NCT03031730
NCT01838434
NCT02697344
NCT00415116
NCT02513186
NCT01126450
NCT01712828
NCT01185262
NCT00179699
NCT00466895
NCT00046735
NCT01155505
NCT00179608
NCT02370888
NCT04326296
NCT00828802
NCT02280525
NCT00698776
NCT00839059
NCT01433965
NCT03558750
NCT01132586
NCT02918331
NCT04436107
NCT04272775
NCT02086604
NCT01034592
NCT02992522
NCT00104962
NCT01207921
NCT03703167
NCT01062152
NCT01750762
NCT02655458
NCT01348503
NCT02600897
NCT02446236
NCT00603447
NCT01183663
NCT01440582
NCT01169298
NCT00671801
NCT01254617
NCT01378091
NCT01742793
NCT00555100
NCT02255162
NCT01116154
NCT02573896
NCT01711554
NCT03506802
NCT02954406
NCT01254578
NCT01393964
NCT02200848
NCT00419250
NCT01352962
NCT01241292
NCT00729118
NCT04301076
NCT03702725
NCT00253344
NCT02492750
NCT01359657
NCT00532675
NCT03359460
NCT01400685
NCT01217203
NCT03110822
NCT02030483
NCT04578600
NCT01953692
NCT03113695
NCT00991562
NCT02886065
NCT01222754
NCT00036894
NCT03050450
NCT00434239
NCT01861340
NCT01537861
NCT04049864
NCT00704691
NCT00907452
NCT03001804
NCT02692339
NCT03903406
NCT02856438
NCT03433001
NCT02537808
NCT01430546
NCT02164955
NCT03098589
NCT03065790
NCT02387879
NCT00633945
NCT02608515
NCT02525250
NCT02863458
NCT02368301
NCT01927718
NCT00899080
NCT01081028
NCT04109872
NCT01347944
NCT04319601
NCT01947309
NCT04036448
NCT02666209
NCT04432402
NCT04435743
NCT02528838
NCT02921815
NCT00890552
NCT02279654
NCT02921802
NCT01752075
NCT02922543
NCT02733224
NCT03715296
NCT02556905
NCT00911105
NCT00792077
NCT01268774
NCT01827137
NCT03647124
NCT01649791
NCT02341781
NCT02741544
NCT02075996
NCT03106324
Intervention Type
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Procedure;Other;Drug
Drug
Other;Biological;Drug
Other;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug;Combination Product
Biological;Drug
Other;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Procedure
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Other;Drug
Other;Drug
Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Radiation;Drug
Procedure;Drug
Biological;Drug
Drug
Other;Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Procedure;Other;Biological;Drug
Other;Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Procedure;Drug;Genetic
Procedure;Drug
Drug
Drug
Drug
Drug
Procedure;Other;Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug;Behavioral
Drug
Biological;Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Other;Biological;Drug;Genetic
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Drug
Other;Procedure;Drug
Drug;Device
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Radiation;Biological;Drug;Genetic
Procedure;Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Drug
Drug
Drug
Procedure;Drug
Drug
Drug;Dietary Supplement
Drug
Other;Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Other;Biological;Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Behavioral
Drug
Drug
Other;Drug
Drug
Biological;Drug
Other;Biological;Drug;Genetic
Drug
Drug
Other;Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Biological;Drug
Biological;Drug
Other;Drug
Other;Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Procedure;Biological;Radiation;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug;Genetic
Drug
Drug
Other;Biological;Drug
Drug
Drug
Other;Biological;Drug
Other;Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Procedure;Other;Drug
Biological;Drug
Drug
Drug
Other;Drug
Other;Drug
Drug
Other;Procedure;Radiation;Drug
Other;Drug
Drug
Other;Biological;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Biological;Drug;Genetic
Biological;Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Drug
Drug
Procedure;Other;Biological;Radiation;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Biological;Drug;Genetic
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Biological;Drug
Drug
Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug;Behavioral
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug;Genetic
Other;Drug
Biological;Drug
Other;Biological;Drug
Procedure;Other;Biological;Radiation;Drug
Drug
Other;Drug
Biological;Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Other;Biological;Drug
Biological
Drug;Combination Product
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Drug
Drug
Biological;Drug
Radiation;Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Diagnostic Test
Drug
Procedure
Drug
Drug;Behavioral
Other;Genetic
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Other;Procedure;Drug
Drug
Indications
AML
Relapsed and/or Refractory Multiple Myeloma
Relapsed Refractory Multiple Myeloma
Multiple Myeloma
Lymphoma, B-Cell
NK/T Cell Lymphoma
Hematologic Neoplasms; Multiple Myeloma; Efficacy; Safety
Newly Diagnosed Multiple Myeloma
Cutaneous Lupus
COVID-19
Peripheral T-cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Follicular Lymphoma; Marginal Zone Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma
Follicular Lymphoma
Anemia; Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome
Plasma Cell Myeloma
Lymphoma; Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
EBV Infection
Relapsed or Refractory Multiple Myeloma
Prostate Cancer
Relapsed/Refractory Follicular Lymphoma
Multiple Myeloma
Newly Diagnosed Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Mantle Cell Lymphoma; Non-Hodgkin's Lymphoma
Myelodysplastic Syndromes
Relapsed Multiple Myeloma; Refractory Multiple Myeloma
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Plasmacytoma
Solitary Osseous Plasmacytoma
Multiple Myeloma
Multiple Myeloma
Complex Regional Pain Syndrome, Type 1
Polycythemia Vera
Follicular Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myeloma
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; New Diagnosis Tumor
Relapsed Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphoma; Diffuse Large B-cell Lymphoma
Multiple Myeloma; Newly Diagnosed Patients
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Newly Diagnosed Multiple Myeloma
MANTLE CELL LYMPHOMA
Smoldering Plasma Cell Myeloma
Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Amyloidosis Cardiac
Multiple Myeloma
Relapsed or Refractory Systemic Light Chain Amyloidosis
Plasma Cell Myeloma
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Previously Untreated Symptomatic Multiple Myeloma
Myelodysplastic Syndrome
Multiple Myeloma; Plasma Cell Neoplasm
Lymphoma, Non-Hodgkin
Plasma Cell Myeloma
Anemia
Multiple Myeloma
B-cell Chronic Lymphocytic Leukemia
Multiple Myeloma
Light Chain Deposition Disease; Smoldering Plasma Cell Myeloma
Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse
Multiple Myeloma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Lymphoma
Multiple Myeloma
Diffuse Large B-cell Lymphoma
Multiple Myeloma
Newly Diagnosed, Previously Untreated Multiple Myeloma
Lymphoma, Non-Hodgkin
Multiple Myeloma; Neoplasms; Plasma Cells; Paraproteinemias; Blood Protein Disorders; Hematologic Diseases; Therapeutic Uses
Plasma Cell Myeloma; RISS Stage I Plasma Cell Myeloma; RISS Stage II Plasma Cell Myeloma
Melanoma; Neoplasm Metastasis
Myeloma
Multiple Myeloma in Relapse; Refractory Multiple Myeloma
B-Cell Chronic Lymphocytic Leukemia
Mantle Cell Lymphoma
Acute Myeloid Leukemia in Remission
Melanoma; Neoplasm Metastasis
Radiculopathy
Multiple Myeloma
Multiple Myeloma in Relapse; Multiple Myeloma Progression; Multiple Myeloma Stage II; Multiple Myeloma Stage I; Multiple Myeloma With Failed Remission; Multiple Myeloma Stage III
Diffuse Large B-cell Lymphoma
Multiple Myeloma
Mantle Cell Lymphoma; Untreated
Multiple Myeloma
Non-Small Cell Lung Cancer
Graft-versus-Host Disease
Primary Amyloidosis
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Newly Diagnosed Multiple Myeloma
Peripheral T-cell Lymphoma
Chronic Lymphocytic Leukemia; CLL; Untreated; Front-line; First-Line; Initial Therapy
Lymphoma; Neurotoxicity; Therapy-related Toxicity
MANTLE CELL LYMPHOMA
Follicular Lymphoma
Myelodysplastic Syndromes
Myelodysplastic Syndromes
Neurofibromatosis Type 1; Recurrent Childhood Pilocytic Astrocytoma; Recurrent Childhood Visual Pathway Glioma
Complex Regional Pain Syndrome (RSD)
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Melanoma
Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)
Leukemia; CLL; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Cognitive Impairment, Mild; Cognitive Dysfunction; Amyloid Plaque; Neurodegeneration; Inflammation, Brain
Kidney Cancer
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma; Transplant-Related Carcinoma
Relapsed or Refractory Peripheral T-cell Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia; CLL
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma in Relapse
Lymphoma
Diffuse Large B-Cell Lymphoma
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Chronic Lymphocytic Leukemia; Leukemia
Multiple Myeloma
Lymphoma
Multiple Myeloma
Ann Arbor Stage II Grade 1 Follicular Lymphoma; Ann Arbor Stage II Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Bulky Disease; Fatigue; Fever; Grade 3a Follicular Lymphoma; Night Sweats; Splenomegaly; Weight Loss
Indolent Non Hodgkin Lymphoma
Leukemia, Chronic Lymphatic
Diffuse Large B Cell Lymphoma; High-grade B-cell Lymphoma; Transformed Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Lymphoma
Multiple Myeloma
Plasmacytoma; Plasmacytoma of Bone; Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Hematopoietic Cell Transplantation Recipient; Plasma Cell Myeloma
Multiple Myeloma
Myelodysplastic Syndrome; Acute Myelogenous Leukemia
Mantle Cell Lymphoma
Diffuse Large B-Cell Lymphoma Refractory
Myelodysplastic Syndromes
Langerhans Cell Histiocytosis (LCH); Histiocytoses Erdheim-chester Disease; Histiocytic Sarcoma (HS)
Myelodysplastic Syndrome; MDS
Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma
Smoldering Multiple Myeloma
Multiple Myeloma
LYMPHOMA
Peripheral T-cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Hematologic Cancer
Relapsed/Refractory Mantle Cell Lymphoma
Multiple Myeloma
Leukemia, Myeloid
Multiple Myeloma
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IA Mycosis Fungoides/Sezary Syndrome; Stage IB Mycosis Fungoides/Sezary Syndrome; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IIA Mycosis Fungoides/Sezary Syndrome; Stage IIB Mycosis Fungoides/Sezary Syndrome; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IIIA Mycosis Fungoides/Sezary Syndrome; Stage IIIB Mycosis Fungoides/Sezary Syndrome; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IVA Mycosis Fungoides/Sezary Syndrome; Stage IVB Mycosis Fungoides/Sezary Syndrome
Squamous Cell Carcinoma
Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse
Leukemia; Lymphoma
Non-hodgkin Lymphoma,B Cell
B-Cell Non-Hodgkin Lymphoma; Hematopoietic and Lymphoid Cell Neoplasm; Leukemia; Lymphoma; Plasma Cell Myeloma; T-Cell Non-Hodgkin Lymphoma
Autism
Multiple Myeloma
Non Hodgkin Lymphoma; Follicular Lymphoma
Liver Cancer
Relapsed or Refractory Chronic Lymphocytic Leukemia
Non-Hodgkins Lymphoma
Leukemia; Relapsed Adult Acute Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Plasma Cell Myeloma; Residual Disease
Lymphoma
Relapse/Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL)
Multiple Myeloma (MM)
Smouldering Myeloma
Plasma Cell Leukemia; Plasma Cell Myeloma
Plasma Cell Myeloma
Chronic Lymphocytic Leukemia
Intraocular Melanoma; Malignant Conjunctival Neoplasm
Renal Failure; Multiple Myeloma
POEMS Syndrome
Essential Thrombocythemia; Polycythemia Vera; Primary Myelofibrosis
Myelodysplastic Syndrome
Adult Myelodysplastic Syndrome; Anemia; Chronic Myelomonocytic Leukemia
MDS
Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Angiogenesis
Multiple Myeloma
Multiple Myeloma
Ann Arbor Stage I Small Lymphocytic Lymphoma; Ann Arbor Stage II Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene; Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Multiple Myeloma
Myeloma, Multiple
Chronic Lymphocytic Leukemia (CLL)
Diffuse Large B-cells Non-Hodgkin Lymphoma
Myelofibrosis
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma (SLL)
Leukemia, Myeloid, Acute
Multiple Myeloma
Monoclonal B-Cell Lymphocytosis; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma
Multiple Myeloma
Colorectal Cancer
Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma
Alkylating Agent-Related Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia
Advanced Cancer; Pain
Multiple Myeloma
Multiple Myeloma
Minimal Residual Disease; Plasma Cell Myeloma
Acute Myeloid Leukemia; Acute Myelogenous Leukemia
Multiple Myeloma
Plasma Cell Myeloma
Myeloma; Newly Diagnosed; High Risk
Multiple Myeloma
Waldenstrom Macroglobulinemia
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Kidney Cancer
Diffuse Large B-cell Lymphoma
Chronic Lymphocytic Leukemia
Thyroid Neoplasms
Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Plasma Cell Myeloma
Amyloidosis
Multiple Myeloma
Multiple Myeloma
Diffuse Large B Cell Lymphoma; Age Over 80 Years
Multiple Myeloma
Myelodysplastic Syndrome MDS
Primary Plasma Cell Leukemia
Mucosa Associated Lymphoid Tissue (MALT) Lymphoma
Leukemia; Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Waldenström's Macroglobulinemia
Diffuse Large B Cell Lymphoma
MDS
Multiple Myeloma
Hematologic Disorder
Myeloproliferative Diseases
Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma
POEMS Syndrome
CAEBV
Primary Systemic Amyloidosis
Multiple Myeloma
Myelodysplastic Syndrome
Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS)
Lymphoid Leukemia; Small Lymphocytic Lymphoma; Lymphoma, Non-Hodgkin
Chronic Lymphocytic Leukemia (CLL)
Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Acute Myeloid Leukemia
Multiple Myeloma
Refractory Primary-cutaneous Large B-cell Lymphoma (Leg-type)
Lymphoma
Chronic Lymphocytic Leukemia
Smoldering Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Non-Hodgkins Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Amyloidosis
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Ann Arbor Stage II Follicular Lymphoma; Ann Arbor Stage II Marginal Zone Lymphoma; Ann Arbor Stage III Follicular Lymphoma; Ann Arbor Stage III Marginal Zone Lymphoma; Ann Arbor Stage IV Follicular Lymphoma; Ann Arbor Stage IV Marginal Zone Lymphoma; CD20 Positive; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Relapse Multiple Myeloma; Refractory Multiple Myeloma
Acute Myeloid Leukemia
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Mantle Cell Lymphoma
Multiple Myeloma; Plasma Cell Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukaemia
Myelodysplastic Syndromes
Adult T-Cell Leukemia-Lymphoma
Prostate Cancer
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
T-cell Lymphoma
Myelodysplastic Syndromes; Thrombocytopenia
Liver Cancer
Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Refractory Follicular Lymphoma
Diffuse Large B Cell Lymphoma
Relapsed and/or Refractory Multiple Myeloma
Hodgkin Disease
Leukemia, Lymphoid; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Multiple Myeloma in Relapse; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myelodysplastic Syndrome
Lymphoma; Relapse
Myelofibrosis
Multiple Myeloma
Acute Myelogenous Leukemia; Myelodysplastic Syndrome
Leukemia
Primary Central Nervous System Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
HIV Infection Associated Kaposi Disease
Chronic Lymphocytic Leukemia (CLL); Small Lymphocytic Lymphoma
EBV Related Non-Hodgkin's Lymphoma; Primary CNS Lymphoma; Primary Testicular Lymphoma
PCNSL
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia
Multiple Myeloma
Myelodysplastic Syndromes
Myelodysplastic Syndrome
Lymphomatoid Papulosis; Primary Cutaneous Anaplastic Large Cell Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma
Multiple Myeloma
Waldenstrom's Macroglobulinemia
Multiple Myeloma
Multiple Myeloma; Amyloidosis
Multiple Myeloma
Multiple Myeloma; Smoldering Multiple Myeloma
Follicular Lymphoma; Marginal Zone Lymphoma
Myelodysplastic Syndrome
Primary CNS Lymphoma
Multiple Myeloma
AML
Adult Acute Basophilic Leukemia; Adult Acute Eosinophilic Leukemia; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Secondary Acute Myeloid Leukemia; Untreated Adult Acute Myeloid Leukemia
Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Recurrent Adult Hodgkin Lymphoma
Multiple Myeloma
Crohn's Disease
Chronic Lymphocytic Leukemia; Leukemia
Hodgkin Disease
Diffuse Large B-Cell Lymphoma Unclassifiable
Multiple Myeloma
Multiple Myeloma
Bladder Cancer
Contiguous Stage II Small Lymphocytic Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage I Small Lymphocytic Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage III Small Lymphocytic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Small Lymphocytic Lymphoma
Lymphoma
Multiple Myeloma; Impaired Renal Function
Chronic Myelomonocytic Leukemia; Chronic Myelomonocytic Leukemia-1; Chronic Myelomonocytic Leukemia-2; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Excess Blasts-1; Myelodysplastic Syndrome With Excess Blasts-2
T-cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphoma
MDS; AML
Acute Myeloid Leukemia
Multiple Myeloma
Chronic Lymphocytic Leukaemia
Acute Myeloid Leukemia
Refractory Plasma Cell Myeloma
Follicular Lymphoma
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic
Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma
MALT Lymphoma
Mantle Cell Lymphoma
Cutaneous T Cell Lymphoma
Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Non Hodgkin's Lymphoma
Follicular Lymphoma; Marginal Zone B-Cell Lymphoma; MALT Lymphoma; Lymphoma of Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Lymphocytic; Waldenstrom Macroglobulinemia; Mantle-Cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma
Multiple Myeloma
Plasma Cell Myeloma; Renal Failure
Mantle Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
CCND1 Positive; CD20-Positive Neoplastic Cells Present; Mantle Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Diffuse Large B-cell Lymphoma
Mantle Cell Lymphoma; Lymphoma, Mantle-Cell
Multiple Myeloma Light Chain Induced Renal Insufficiency
Chronic Lymphocytic Leukemia
Recurrent Primary Amyloidosis
Myelodysplastic Syndrome
Complex Regional Pain Syndrome, Type I
Smoldering Multiple Myeloma
Multiple Myeloma
Newly Diagnosed Multiple Myeloma
Mantle Cell Lymphoma
Multiple Myeloma
Prostate Cancer
Chronic Lymphocytic Leukemia; Fatigue; Fever; Hypogammaglobulinemia; Lymphadenopathy; Lymphocytosis; Night Sweats; Paraproteinemia; Small Lymphocytic Lymphoma; Thrombocytopenia
Smoldering Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Metastatic Prostate Cancer
Multiple Myeloma
Prostate Cancer
Newly Diagnosed Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndromes; Acute Myelogenous Leukemia
Neuropathy; Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)
Primary Intraocular Lymphoma
Leukemia; Lymphoma
Multiple Myeloma
Multiple Myeloma
T-cell Non-Hodgkin's Lymphoma
Multiple Myeloma
Multiple Myeloma
Myeloma
Lymphoma
Multiple Myeloma
MULTIPLE MYELOMA (MM)
Plasma Cell Disorder
POEMS Syndrome
Chronic Lymphocytic Leukemia
Myelodysplastic Syndromes
Diffuse Large B-cell Lymphoma
Recurrent Mantle Cell Lymphoma
Glioblastoma; Gliosarcoma; Malignant Gliomas
Myelodysplastic Syndromes
Diffuse Large B Cell Lymphoma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Multiple Myeloma
Mantle Cell Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myeloma
Metastatic Pancreatic Cancer
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphocytic Leukemia; Mantle Cell Lymphoma
NK/T Cell Lymphoma Nos
Multiple Myeloma
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Multiple Myeloma
Adult T Cell Leukemia/Lymphoma
POEMS Syndrome
Leukemia
Multiple Myeloma
Myeloma Multiple; Myeloma, Plasma-Cell; Myeloma-Multiple; Plasma Cell Myeloma
Multiple Myeloma
Smoldering Myeloma; Smoldering Multiple Myeloma
Hematopoietic Cell Transplantation Recipient; Plasma Cell Myeloma
Leukemia
Myeloma
Plasmacytoma; POEMS Syndrome
Myeloma; Multiple Myeloma
Multiple Myeloma
Refractory Large B-cell Lymphoma
Lymphoma, Non-Hodgkin's
Relapsed Hematologic Malignancy; Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Refractory Multiple Myeloma; Smoldering Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myeloma; Stem Cell Transplantation
Adult Grade III Lymphomatoid Granulomatosis; B-cell Chronic Lymphocytic Leukemia; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Progressive Hairy Cell Leukemia, Initial Treatment; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage 0 Chronic Lymphocytic Leukemia; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Small Lymphocytic Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Testicular Lymphoma; Untreated Hairy Cell Leukemia; Waldenström Macroglobulinemia
Leukemia
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Ovarian Cancer Recurrent
Multiple Myeloma
Multiple Myeloma
Non Hodgkin Lymphoma
Multiple Myeloma; Kahler Disease; Plasma-Cell Myeloma; Myelomatosis
Multiple Myeloma
B Cell Lymphoma; Lymphoma
Anaplastic Large Cell Lymphoma, ALK-Negative; Anaplastic Large Cell Lymphoma, ALK-Positive; Hepatosplenic T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Stage II Angioimmunoblastic T-cell Lymphoma; Stage II Enteropathy-Associated T-Cell Lymphoma; Stage III Angioimmunoblastic T-cell Lymphoma; Stage III Enteropathy-Associated T-Cell Lymphoma; Stage IV Angioimmunoblastic T-cell Lymphoma; Stage IV Enteropathy-Associated T-Cell Lymphoma
Primary Effusion Lymphoma; B-Cell Neoplasm
Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell
Lymphoma
Lymphoma, Follicular
Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Chronic Myelomonocytic Leukemia
Multiple Myeloma
AIDS-Related Kaposi Sarcoma; Recurrent Kaposi Sarcoma
Chronic Lymphocytic Leukemia; Leukemia
Diffuse Large B-cell Lymphoma (DLBCL); Follicular Lymphoma Grade III (FL III°); Mantle Cell Lymphoma (MCL), Blastoid Variant; Burkitt Lymphoma (BL); Aggressive Marginal Zone Lymphoma (MZL)
Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Follicular Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Small Lymphocytic Lymphoma
Recurrent Adult Hodgkin Lymphoma
Refractory Multiple Myeloma
Relapsed or Refractory Solid Tumors; Nonsmall Cell Lung Cancer
Follicular Lymphoma Patients (Phase IB); Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
Myelodysplastic Syndrome; MDS; Low to Intermediate-1 MDS; Non-deletion 5q
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndromes
Multiple Myeloma
Lymphoma
Prostate Cancer
Renal Cell Carcinoma
Acute Myeloid Leukemia (AML); Adult Acute Myeloblastic Leukemia
Multiple Myeloma
PTCL, NOS; AITL; ALK- ALCL; Phase III-IV ALK+ ALCL; EATL
Non-Hodgkin's Lymphoma
Multiple Myeloma
Lymphoma
Waldenstrom Macroglobulinemia
Multiple Myeloma
Myeloma Multiple
B-cell Lymphoma
Peripheral T-Cell Non-Hodgkin's Lymphoma
Myelodysplastic Syndrome; Acute Myeloid Leukemia
Leukemia, Myeloid, Acute
Myeloma
Multiple Myeloma
Follicular Lymphoma
Recurrent Chronic Lymphocytic Leukemia
Leukemia; Myelodysplastic Syndromes
Relapsed Hodgkin Lymphoma; Relapsed Non-Hodgkin Lymphoma
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Pancreas Cancer; Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma
Refractory Differentiated Thyroid Gland Carcinoma; Refractory Thyroid Gland Follicular Carcinoma; Refractory Thyroid Gland Hurthle Cell Carcinoma; Refractory Thyroid Gland Papillary Carcinoma; Unresectable Thyroid Gland Carcinoma
Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Pancreatic Cancer
B-cell Adult Acute Lymphoblastic Leukemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia
Pancreatic Carcinoma.
Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse; Central Nervous System Neoplasms, Primary
Lymphoma, Large B-Cell, Diffuse; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma
Anaplastic Large Cell Lymphoma, ALK-Negative; Recurrent Anaplastic Large Cell Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma; Follicular Lymphoma
Cancer Cachexia Syndrome
Folliculotropic Mycosis Fungoides; Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified; Sezary Syndrome; Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia in Remission
CLL; Chronic Lymphocytic Leukemia
Relapsed Diffuse Large B-Cell Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Amyloidosis
Plasma Cell Leukemia in Remission; Plasma Cell Myeloma
Leukemia, Lymphocytic, Chronic, B-Cell
Diffuse Large B-cell Lymphoma.
Multiple Myeloma
Refractory Multiple Myeloma
Diffuse Large B Cell Lymphoma Relapsed; Diffuse Large B Cell Lymphoma Refractory
Multiple Myeloma
Multiple Myeloma; Plasma Cell Neoplasm
T-cell Lymphomas; Relapsed or Refractory
DLBCL; Untreated; MYC Gene Rearrangement
Amyloidosis
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
AIDS-Related Hodgkin Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Waldenstrom Macroglobulinemia
Solid Tumors
Multiple Myeloma
Mantle Cell Lymphoma
Ovarian Cancer
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Multiple Myeloma; Non-Hodgkin's Lymphoma
Relapse; Refractory Multiple Myeloma
Multiple Myeloma
Low- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)
Chronic Lymphatic Leukemia
DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma
Diffuse Large B-cell Lymphoma
Primary Central Nervous System Lymphoma
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
Lymphoma; Follicular Lymphoma
Multiple Myeloma
Prostate Cancer
Non-Hodgkins Lymphoma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; B-cell Lymphomas; Marginal Zone Lymphoma; Mantle Cell Lymphoma; Waldenstrom's Macroglobulinemia
Multiple Myeloma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Transformed Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Transformed Non-Hodgkin Lymphoma
Grade 3a Follicular Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma
Lymphoma
Lymphoma
HIV-1 Infection
Urinary Bladder Neoplasms
Chronic Lymphocytic Leukemia
Multiple Myeloma
Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
Multiple Myeloma
Multiple Myeloma
Adenocarcinoma of the Prostate; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer
Ovarian Cancer
Multiple Myeloma
Solid Tumors; Advanced Malignancies; Metastatic Cancer
Hematologic Malignancies; Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Advanced Cancers
Leukemia
Hodgkin Lymphoma
Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Multiple Myeloma
Myeloma, Multiple
Refractory/Relapsed Indolent Non-Hodgkin Lymphoma
Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
Multiple Myeloma
Advanced Cancer, Various, NOS
Non Hodgkins Lymphoma; Diffuse Large B-cell Lymphoma
Myelodysplastic Syndromes; Acute Myelogenous Leukemia
Smoldering Multiple Myeloma
Recurrent Follicular Lymphoma
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Recurrent Adult Acute Myeloid Leukemia
Prostate Cancer
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Melanoma
Multiple Myeloma
Acute Myeloid Leukemia
B-cell Chronic Lymphocytic Leukemia
Multiple Myeloma in Relapse
Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Carcinoma; Primary Peritoneal Carcinoma
Multiple Myeloma
Childhood Atypical Teratoid/Rhabdoid Tumor; Childhood Central Nervous System Germ Cell Tumor; Childhood Choroid Plexus Tumor; Childhood Craniopharyngioma; Childhood Ependymoblastoma; Childhood Grade I Meningioma; Childhood Grade II Meningioma; Childhood Grade III Meningioma; Childhood High-grade Cerebellar Astrocytoma; Childhood High-grade Cerebral Astrocytoma; Childhood Infratentorial Ependymoma; Childhood Low-grade Cerebellar Astrocytoma; Childhood Low-grade Cerebral Astrocytoma; Childhood Medulloepithelioma; Childhood Mixed Glioma; Childhood Oligodendroglioma; Childhood Supratentorial Ependymoma; Recurrent Childhood Brain Tumor; Recurrent Childhood Cerebellar Astrocytoma; Recurrent Childhood Cerebral Astrocytoma; Recurrent Childhood Ependymoma; Recurrent Childhood Medulloblastoma; Recurrent Childhood Pineoblastoma; Recurrent Childhood Subependymal Giant Cell Astrocytoma; Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor; Recurrent Childhood Visual Pathway and Hypothalamic Glioma
Plasma Cell Leukemia
Relapsed/Refractory B-cell Lymphoma
Recurrent/Refractory CNS; Intraocular Lymphoma
Anemia; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Thrombocytopenia
CD30-Positive Neoplastic Cells Present; Folliculotropic Mycosis Fungoides; Recurrent Mycosis Fungoides; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Sezary Syndrome
Multiple Myeloma
Refractory Multiple Myeloma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple Myeloma
Myeloma
Leukemia Lymphocytic Chronic B-Cell
Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Grade 1 Follicular Lymphoma; Ann Arbor Stage III Grade 2 Follicular Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Grade 1 Follicular Lymphoma; Ann Arbor Stage IV Grade 2 Follicular Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma
Myeldysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia; Bone Marrow Diseases; Neutropenia; Acute Myeloid Leukemia (AML)
Multiple Myeloma and Plasma Cell Neoplasm
Solid Tumors
Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Hodgkin Lymphoma
Acute Myelogenous Leukemia
Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma
Recurrent B-Cell Prolymphocytic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory B-Cell Prolymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma
Multiple Myeloma
Multiple Myeloma
Advanced Cancers
Multiple Myeloma
Multiple Myeloma
Healthy, Male
Lymphoma
Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia
Carcinoma, Non-Small-Cell Lung
Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic; Multiple Myeloma
Refractory Multiple Myeloma
Mantle Cell Lymphoma
Myelodysplastic Syndrome (MDS)
Acute Leukemia
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Ann Arbor Stage III Small Lymphocytic Lymphoma; Ann Arbor Stage IV Small Lymphocytic Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Small Lymphocytic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia
Multiple Myeloma
Myelodysplastic Syndrome; Acute Myeloid Leukemia
Solid Tumors
Plasma Cell Myeloma
Leukemia, Lymphocytic, Chronic, B-Cell
Multiple Myeloma
Leukemia, Lymphocytic, Chronic, B-Cell; Chronic Lymphocytic Leukemia; Lymphoma, Small Lymphocytic
Partial Response of Multiple Myeloma or Plasma Cell Leukemia; Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Chronic Lymphocytic Leukemia; Small Lymphocytic Leukemia
Demyelinating Sensorimotor Neuropathy
Lymphoma; Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Burkitt Lymphoma
Solid Organ Malignancies; Adenoidcystic Carcinoma; Neuroendocrine Tumors
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Grade 3b Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mediastinal Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Mediastinal Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia; Non-Hodgkin's Lymphoma
Multiple Myeloma
Adult Non-Hodgkin Lymphoma; Adult Grade III Lymphomatoid Granulomatosis; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Waldenstrom Macroglobulinemia
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Follicular Lymphoma; Recurrent Indolent Adult Non-Hodgkin Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Follicular Lymphoma; Refractory Indolent Adult Non-Hodgkin Lymphoma; Refractory Marginal Zone Lymphoma
Indolent Non-Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma
Diffuse Large B-cell Lymphoma
Healthy Volunteers
Relapsed/Refractory T-cell Malignancies; Cutaneous T-Cell Lymphoma; Mature T-cell Malignancies; Peripheral T-Cell Lymphoma
Central Nervous System Lymphoma; Diffuse Large B-Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Recurrent Follicular Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Nodal Marginal Zone Lymphoma; Recurrent Splenic Marginal Zone Lymphoma; Recurrent Waldenstrom Macroglobulinemia; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Refractory Follicular Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Nodal Marginal Zone Lymphoma; Refractory Splenic Marginal Zone Lymphoma; Refractory Waldenstrom Macroglobulinemia
Myeloma
Follicular Lymphoma
Myelodysplasia
Multiple Myeloma
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Hodgkin Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Small Lymphocytic Lymphoma; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome
Multiple Myeloma
Multiple Myeloma
Immunoglobulin G Subclass 4 Related Disease; IgG4-related Disease; Autoimmune Pancreatitis; IgG4-related Sclerosing Cholangitis; Retroperitoneal Fibrosis
Plasmacytoma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Relapsed/Refractory Mantle Cell Lymphoma
Recurrent Plasma Cell Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Plasma Cell Myeloma
Colon Cancer; Rectal Cancer
Healthy
Chronic Lymphocytic Leukemia
Non-Small Cell Lung Cancer
Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Chronic Lymphocytic Leukemia
Neoplasms
Advanced Solid Tumors
Malignant Melanoma
Leukemia, Myeloid; Myelodysplastic Syndromes
Colorectal Neoplasms
Myelodysplastic Syndromes
Leukemia
Myeloma
Acute Myeloid Leukemia
Acute Myeloid Leukemia; Myelodysplastic Syndrome
Recurrent Central Nervous System Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Refractory Central Nervous System Lymphoma; Refractory Diffuse Large B-Cell Lymphoma
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL; Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA; Alkylating Agent-Related Acute Myeloid Leukemia; de Novo Myelodysplastic Syndrome; Previously Treated Myelodysplastic Syndrome; Recurrent Adult Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndrome; Untreated Adult Acute Myeloid Leukemia
Multiple Myeloma
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Relapsed and/or Refractory Multiple Myeloma
Lymphoma, Large B-Cell, Diffuse
Anemia; Leukemia; Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS)
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma; Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory Burkitt Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Follicular Lymphoma; Transformed Recurrent Non-Hodgkin Lymphoma
Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ringed Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Secondary Myelodysplastic Syndromes; Unspecified Childhood Solid Tumor, Protocol Specific
Hodgkin Disease
Primary Central Nervous System Lymphoma (PCNSL); Secondary Central Nervous System Lymphoma (SCNSL)
Myelodysplastic Syndrome
Multiple Myeloma; Lymphoma
Multiple Myeloma
Hepatocellular Carcinoma
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Mantle Cell Lymphoma
Relapsed Multiple Myeloma
Advanced Cancers
Myeloma
Adult T-cell Leukemia-Lymphoma; Peripheral T-cell Lymphoma
Malignant Gliomas
Recurrent Colon Carcinoma; Recurrent Hypopharyngeal Squamous Cell Carcinoma; Recurrent Laryngeal Squamous Cell Carcinoma; Recurrent Laryngeal Verrucous Carcinoma; Recurrent Lip and Oral Cavity Squamous Cell Carcinoma; Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary; Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma; Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma; Recurrent Oral Cavity Verrucous Carcinoma; Recurrent Oropharyngeal Squamous Cell Carcinoma; Recurrent Rectal Carcinoma; Recurrent Salivary Gland Carcinoma; Salivary Gland Squamous Cell Carcinoma; Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary; Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7; Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7; Stage IVA Colon Cancer AJCC v7; Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IVA Laryngeal Verrucous Carcinoma AJCC v7; Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IVA Major Salivary Gland Cancer AJCC v7; Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7; Stage IVA Oral Cavity Cancer AJCC v6 and v7; Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7; Stage IVA Rectal Cancer AJCC v7; Stage IVB Colon Cancer AJCC v7; Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IVB Laryngeal Verrucous Carcinoma AJCC v7; Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IVB Major Salivary Gland Cancer AJCC v7; Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7; Stage IVB Oral Cavity Cancer AJCC v6 and v7; Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7; Stage IVB Rectal Cancer AJCC v7; Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7; Stage IVC Laryngeal Verrucous Carcinoma AJCC v7; Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7; Stage IVC Major Salivary Gland Cancer AJCC v7; Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7; Stage IVC Oral Cavity Cancer AJCC v6 and v7; Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7; Tongue Carcinoma
Prostate Cancer
Hodgkin's Lymphoma; Mature T-cell Lymphoma; Multiple Myeloma
Multiple Myeloma
Acute Myeloid Leukemia (AML); Acute Myelocytic Leukemia; Acute Myelogenous Leukemia; Acute Granulocytic Leukemia; Acute Non-Lymphocytic Leukemia
Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-Cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Neuroblastoma
Recurrent Neuroblastoma; Refractory Neuroblastoma
HLA-A*0201 Positive Cells Present; NY-ESO-1 Positive Tumor Cells Present; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Lymphoma, Non-Hodgkin
Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A; Adult Acute Promyelocytic Leukemia With PML-RARA; Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-Cell Lymphoma; Alkylating Agent-Related Acute Myeloid Leukemia; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-Cell Lymphoma; Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Hepatosplenic T-Cell Lymphoma; Intraocular Lymphoma; Lymphomatous Involvement of Non-Cutaneous Extranodal Site; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Nodal Marginal Zone Lymphoma; Post-Transplant Lymphoproliferative Disorder; Primary Cutaneous B-Cell Non-Hodgkin Lymphoma; Prolymphocytic Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-Cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides and Sezary Syndrome; Recurrent Non-Hodgkin Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Richter Syndrome; Small Intestinal Lymphoma; Splenic Marginal Zone Lymphoma; T-Cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenstrom Macroglobulinemia
Multiple Myeloma
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia; Leukemia, B-Cell, Chronic
Urethral Neoplasms; Neoplasms, Urethral; Cancer of the Urethra; Urethral Cancer
Multiple Myeloma
Multiple Myeloma; Plasma Cell Neoplasm
Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection
Refractory Multiple Myeloma; Multiple Myeloma in Relapse; Multiple Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Indolent Plasma Cell Myeloma; Plasma Cell Myeloma; Smoldering Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Myelodysplastic Syndrome; Previously Treated Myelodysplastic Syndrome; Refractory High Risk Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome; Therapy-Related Myelodysplastic Syndrome
Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; B Chronic Lymphocytic Leukemia
Patients With Multiple Myeloma Experiencing a; First or Second Relapse
Multiple Myeloma
Multiple Myeloma
Indolent B-Cell Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Chronic Lymphocytic Leukemia; Recurrent Mucosa-Associated Lymphoid Tissue Lymphoma; Recurrent Follicular Lymphoma; Recurrent Hairy Cell Leukemia; Recurrent Lymphoplasmacytic Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Mucosa-Associated Lymphoid Tissue Lymphoma; Refractory Follicular Lymphoma; Refractory Hairy Cell Leukemia; Refractory Lymphoplasmacytic Lymphoma; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Small Lymphocytic Lymphoma
Myelodysplastic Syndrome; Multiple Myeloma; Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Primary Mediastinal B-Cell Lymphoma
Richter's Syndrome; CLL
Multiple Myeloma
Smoldering Multiple Myeloma
Diffuse Intrinsic Pontine Glioma; Anaplastic Astrocytoma; High Grade Glioma
Brain and Central Nervous System Tumors
Central Nervous System Tumors
Myelodysplasia
Myeloma
Multiple Myeloma
Relapsed Neuroblastoma
Peripheral T-cell Lymphomas; Adult T-cell Leukemia; Adult T-cell Lymphoma; Peripheral T-cell Lymphoma Unspecified; Angioimmunoblastic T-cell Lymphoma; Anaplastic Large Cell Lymphoma; T/Null Cell Systemic Type; Cutaneous t-Cell Lymphoma With Nodal/Visceral Disease
Myeloma
Multiple Myeloma
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma
Cutaneous Lupus Erythematosus (CLE)
Relapsed/Refractory Multiple Myeloma
Acute Myeloid Leukemia or Myelodysplasic Syndrome
Acute Myeloid Leukemia; Myelodysplastic Syndromes
Multiple Myeloma
Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Mantle Cell Lymphoma
Myelodysplastic Syndrome
Angioimmunoblastic T-cell Lymphoma; Chemotherapy Effect; Chemotherapeutic Toxicity
Multiple Myeloma
Myelodysplastic Syndromes; Lymphoma, Mantle-Cell
Multiple Myeloma in Relapse; Multiple Myeloma
Diffuse Large B Cell Lymphoma
Non-hodgkin Lymphoma,B Cell
Multiple Myeloma
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute
Leukemia; Amyloidosis
Myelodysplastic Syndrome
Multiple Myeloma; Myelodysplastic Syndromes
Multiple Myeloma
Multiple Myeloma
Patient Non-adherence
Diffuse Large B Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Leukemia; CLL
Multiple Myeloma
Multiple Myeloma; Minimal Residual Disease; High-Risk Cancer
Lymphoma, Mantle-Cell
B-cell Chronic Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Stage 0 Chronic Lymphocytic Leukemia; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia
Lymphoma, Mantle-Cell
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Study Phase
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 4
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Terminated
Active, not recruiting
Recruiting
Completed
Recruiting
Recruiting
Recruiting
Recruiting
Completed
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Terminated
Completed
Active, not recruiting
Terminated
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Unknown status
Recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Terminated
Completed
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Withdrawn
Recruiting
Completed
Completed
Recruiting
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Terminated
Active, not recruiting
Completed
Completed
Terminated
Completed
Completed
Active, not recruiting
Terminated
Unknown status
Active, not recruiting
Completed
Completed
Completed
Terminated
Active, not recruiting
Completed
Active, not recruiting
Completed
Terminated
Completed
Terminated
Recruiting
Completed
Terminated
Completed
Completed
Terminated
Active, not recruiting
Withdrawn
Terminated
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Unknown status
Recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Completed
Completed
Not yet recruiting
Active, not recruiting
Withdrawn
Unknown status
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Recruiting
Completed
Terminated
Unknown status
Completed
Completed
Completed
Terminated
Recruiting
Recruiting
Terminated
Suspended
Active, not recruiting
Withdrawn
Withdrawn
Completed
Terminated
Recruiting
Active, not recruiting
Recruiting
Recruiting
Completed
Withdrawn
Terminated
Completed
Completed
Completed
Terminated
Recruiting
Terminated
Completed
Active, not recruiting
Completed
Active, not recruiting
Withdrawn
Active, not recruiting
Not yet recruiting
Withdrawn
Active, not recruiting
Completed
Withdrawn
Completed
Recruiting
Completed
Withdrawn
Terminated
Recruiting
Recruiting
Terminated
Terminated
Completed
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Terminated
Completed
Recruiting
Active, not recruiting
Completed
Terminated
Completed
Completed
Completed
Active, not recruiting
Completed
Withdrawn
Active, not recruiting
Recruiting
Recruiting
Terminated
Completed
Active, not recruiting
Withdrawn
Completed
Recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
Terminated
Completed
Completed
Recruiting
Completed
Recruiting
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Active, not recruiting
Unknown status
Completed
Completed
Active, not recruiting
Completed
Suspended
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Withdrawn
Completed
Completed
Active, not recruiting
Recruiting
Completed
Completed
Terminated
Completed
Withdrawn
Recruiting
Terminated
Completed
Completed
Terminated
Unknown status
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Unknown status
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Completed
Terminated
Completed
Withdrawn
Recruiting
Terminated
Not yet recruiting
Unknown status
Completed
Recruiting
Terminated
Terminated
Active, not recruiting
Recruiting
Recruiting
Enrolling by invitation
Terminated
Terminated
Recruiting
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Unknown status
Recruiting
Completed
Completed
Completed
Active, not recruiting
Terminated
Completed
Terminated
Recruiting
Completed
Terminated
Completed
Completed
Unknown status
Recruiting
Unknown status
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Terminated
Unknown status
Terminated
Recruiting
Completed
Completed
Recruiting
Active, not recruiting
Completed
Withdrawn
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Unknown status
Completed
Recruiting
Unknown status
Terminated
Active, not recruiting
Recruiting
Recruiting
Recruiting
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Not yet recruiting
Completed
Recruiting
Completed
Completed
Completed
Terminated
Terminated
Recruiting
Active, not recruiting
Completed
Terminated
Terminated
Completed
Unknown status
Completed
Unknown status
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Completed
Completed
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Completed
Completed
Recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Recruiting
Completed
Active, not recruiting
Recruiting
Completed
Unknown status
Completed
Not yet recruiting
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Terminated
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Unknown status
Completed
Completed
Completed
Recruiting
Completed
Active, not recruiting
Unknown status
Withdrawn
Recruiting
Completed
Completed
Completed
Recruiting
Completed
Terminated
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Active, not recruiting
Terminated
Suspended
Unknown status
Completed
Completed
Withdrawn
Terminated
Active, not recruiting
Unknown status
Completed
Terminated
Active, not recruiting
Terminated
Completed
Completed
Active, not recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
Completed
Terminated
Completed
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Completed
Withdrawn
Completed
Terminated
Completed
Completed
Completed
Completed
Recruiting
Terminated
Completed
Terminated
Active, not recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Terminated
Withdrawn
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Completed
Recruiting
Terminated
Completed
Active, not recruiting
Completed
Unknown status
Withdrawn
Completed
Unknown status
Completed
Completed
Completed
Terminated
Terminated
Active, not recruiting
Recruiting
Completed
Unknown status
Active, not recruiting
Terminated
Completed
Unknown status
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Active, not recruiting
Completed
Withdrawn
Completed
Completed
Active, not recruiting
Completed
Recruiting
Completed
Completed
Completed
Withdrawn
Terminated
Completed
Completed
Unknown status
Recruiting
Recruiting
Active, not recruiting
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Completed
Terminated
Terminated
Unknown status
Terminated
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Not yet recruiting
Terminated
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Terminated
Active, not recruiting
Terminated
Completed
Completed
Withdrawn
Completed
Completed
Completed
Withdrawn
Active, not recruiting
Terminated
Completed
Completed
Active, not recruiting
Completed
Terminated
Completed
Recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Terminated
Recruiting
Completed
Completed
Terminated
Terminated
Terminated
Completed
Withdrawn
Not yet recruiting
Recruiting
Completed
Terminated
Completed
Completed
Active, not recruiting
Terminated
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Terminated
Recruiting
Active, not recruiting
Active, not recruiting
Terminated
Recruiting
Recruiting
Completed
Recruiting
Completed
Recruiting
Terminated
Recruiting
Completed
Active, not recruiting
Completed
Recruiting
Not yet recruiting
Not yet recruiting
Terminated
Recruiting
Completed
Completed
Active, not recruiting
Active, not recruiting
Active, not recruiting
Completed
Recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Terminated
Completed
Completed
Terminated
Completed
Completed
Unknown status
Completed
Terminated
Not yet recruiting
Completed
Active, not recruiting
Completed
Terminated
Active, not recruiting
Terminated
Completed
Completed
Recruiting
Terminated
Active, not recruiting
Terminated
Suspended
Completed
Active, not recruiting
Recruiting
Completed
Terminated
Completed
Terminated
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Terminated
Completed
Terminated
Terminated
Recruiting
Active, not recruiting
Withdrawn
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Recruiting
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Completed
Completed
Recruiting
Terminated
Recruiting
Completed
Recruiting
Completed
Recruiting
Completed
Completed
Suspended
Unknown status
Completed
Terminated
Recruiting
Terminated
Completed
Recruiting
Recruiting
Not yet recruiting
Available
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Active, not recruiting
Approved for marketing
Terminated
Completed
Active, not recruiting
Recruiting
Completed
Recruiting
Terminated
Not yet recruiting
No longer available
Recruiting
Recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Unknown status
Recruiting
Completed
Completed
Completed
Completed
Active, not recruiting
Recruiting
Terminated
Completed
Active, not recruiting
Active, not recruiting
Recruiting
Pomalidomide
CDC-394, CC-4047, IMiD-1, IMID-4047
Approved
Celgene Corp
Medulloblastoma, Lymphoma, B-Cell, Bone Marrow Neoplasms, Hodgkin Disease, Scleroderma, Systemic, Lymphoma, Large B-Cell, Diffuse, Multiple Myeloma, Central Nervous System Neoplasms, Lung Diseases, Interstitial, Prostatic Neoplasms, Sarcoma, Lymphoma, Follicular, Primary Myelofibrosis, Lymphoma, Non-Hodgkin, Carcinoma, Small Cell, Neoplasm Metastasis, Sarcoma, Kaposi, Anemia, Sickle Cell, Leukemia, Lymphocytic, Chronic, B-Cell
NCT Number
NCT01311687
NCT01712789
NCT03440411
NCT03151811
NCT04484623
NCT02990338
NCT03539744
NCT01178281
NCT02726581
NCT03651128
NCT01243944
NCT01324947
NCT04181827
NCT02916420
NCT01734928
NCT03143049
NCT03180736
NCT02576977
NCT02718833
NCT01159574
NCT01745588
NCT04287855
NCT03113942
NCT02807454
NCT04661137
NCT04584307
NCT02654132
NCT02578121
NCT03590652
NCT02244125
NCT01177735
NCT02406222
NCT01794039
NCT03713294
NCT01745640
NCT04191616
NCT03601624
NCT02046915
NCT01946477
NCT03959358
NCT01688466
NCT01319422
NCT04270175
NCT03520985
NCT01053949
NCT03910244
NCT02158702
NCT04302324
NCT03030261
NCT03170882
NCT02045017
NCT03215524
NCT01559129
NCT04176718
NCT04305444
NCT00072722
NCT04700176
NCT03841565
NCT03227432
NCT03242460
NCT00770757
NCT02176213
NCT04124497
NCT04508790
NCT03601806
NCT03756896
NCT02294357
NCT00558896
NCT03104270
NCT02612779
NCT03567616
NCT02011113
NCT00463385
NCT03683277
NCT03202628
NCT03257631
NCT02188368
NCT04577755
NCT00717522
NCT00946270
NCT01510613
NCT00949364
NCT02547662
NCT01135199
NCT01495598
NCT01212952
NCT04150965
NCT01638936
NCT01166113
NCT01464034
NCT02228512
NCT02004275
NCT03715478
NCT02548962
NCT02343042
NCT01570387
NCT02119468
NCT01997840
NCT00669578
NCT01754402
NCT01644110
NCT04094961
NCT02185820
NCT01522872
NCT00833833
NCT00540579
NCT02384083
NCT00537511
NCT01946152
NCT01665794
NCT02542657
NCT01979276
NCT02206425
NCT01421186
NCT01541332
NCT04643002
NCT01592370
NCT01432600
NCT02661022
NCT02289222
NCT02265510
NCT02029950
NCT01722305
NCT03023527
NCT02939183
NCT01568294
NCT03605719
NCT01562405
NCT03798314
NCT01707407
NCT01835561
NCT02462525
NCT04667663
NCT02431208
NCT02415153
NCT02287558
NCT02283775
NCT02189343
NCT02400242
NCT01575925
NCT02569320
NCT00482521
NCT02900716
NCT03657420
NCT01998971
NCT02168205
NCT02616640
NCT01078974
NCT04392648
NCT01889420
NCT03143985
NCT01986894
NCT02103335
NCT03424928
NCT04355039
NCT01198067
NCT03015922
NCT01728259
NCT04045795
NCT01999335
NCT01497093
NCT01522547
NCT01474330
NCT02659930
NCT01807286
NCT01537861
NCT03723096
NCT02921828
NCT02902900
NCT01632826
NCT03353545
NCT02555839
NCT02075996
NCT03288974
NCT02164955
Intervention Type
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Procedure;Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Other;Biological;Drug
Drug
Drug
Drug
Drug;Dietary Supplement
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Other;Drug
Other;Drug
Drug
Drug
Drug
Biological;Drug
Drug
Biological;Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug;Behavioral
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma
Multiple Myeloma
Primary Myelofibrosis; MPN-associated Myelofibrosis
Multiple Myeloma
Multiple Myeloma
Polycythemia Vera
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Relapse Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma in Relapse; Multiple Myeloma, Refractory
High Grade Squamous Intra-epithelial Lesion (HSIL)
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Multiple Myeloma; First Relapse
Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Refractory Plasma Cell Myeloma
Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma in Relapse; Multiple Myeloma Progression; Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; Amyloidosis
Graft vs Host Disease; Graft-Versus-Host Disease
Multiple Myeloma
Amyloid; AL Amyloidosis; Refractory AL Amyloidosis
Refractory Multiple Myeloma
Multiple Myeloma
Telangiectasia, Hereditary Hemorrhagic
Multiple Myeloma; Relapse After Use of Lenalidomide and Bortezomib
Multiple Myeloma; Refractory Multiple Myeloma; Relapse Multiple Myeloma
Multiple Myeloma in Relapse
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Scleroderma, Systemic; Sclerosis, Systemic; Systemic Scleroderma; Systemic Sclerosis; Interstitial Lung Disease
Multiple Myeloma; Refractory Multiple Myeloma; Multiple Myeloma in Relapse; Relapse
Relapsed Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Diffuse Large B Cell Lymphoma; Follicular Lymphoma; Richter's Transformation
Prostate Cancer
Multiple Myeloma
Recurrent Plasma Cell Myeloma
Multiple Myeloma
Relapsed and/or refractorY Multiple Myeloma
Graft vs Host Disease
Multiple Myeloma in Relapse; Multiple Myeloma, Refractory
Multiple Myeloma; Deletion 17P Syndrome
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Human Immunodeficiency Virus 1 Positive; Skin Kaposi Sarcoma
Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Myelofibrosis With Myeloid Metaplasia; Myeloid Metaplasia; Myelofibrosis
Multiple Myeloma; Relapsed and Refractory Multiple Myeloma; Genetic Condition
Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Central Nervous System Neoplasms; Medulloblastoma
Multiple Myeloma
Skin Kaposi Sarcoma
Soft Tissue Sarcoma
Polycythemia Vera; Thrombocythemia
Primary Amyloidosis of Light Chain Type
Myeloproliferative Neoplasms
Plasma Cell Leukemia; Plasma Cell Myeloma; Plasmacytoma
Pulmonary Fibrosis
Kaposi Sarcoma; Sarcoma, Kaposi
Refractory Multiple Myeloma
Multiple Myeloma; Relapsed Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease; Primary Effusion Lymphoma
Multiple Myeloma in Relapse
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
AL Amyloidosis
Refractory Plasma Cell Myeloma; Recurrent Plasma Cell Myeloma
Multiple Myeloma
Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
Multiple Myeloma
Primary Myelofibrosis; Secondary Myelofibrosis; PMF; SMF; Post-PV MF; Post-ET MF
Multiple Myeloma; Multiple Myeloma in Relapse
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Pancreatic Cancer
Multiple Myeloma
Carcinoma, Small Cell
Multiple Myeloma-Light Chain Only; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Multiple Myeloma
Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Plasma Cell Myeloma Refractory
Non-Hodgkin's Lymphoma; Hodgkin Lymphoma; Multiple Myeloma
Myeloma
Multiple Myeloma
Multiple Myeloma
Solid Tumors; Advanced Malignancies; Metastatic Cancer
Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia-2; High Risk Myelodysplastic Syndrome; Myeloproliferative Neoplasm
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma; Central Nervous System Lymphoma; Intraocular Lymphoma; Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System; Recurrent Adult Diffuse Large Cell Lymphoma; Retinal Lymphoma
Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Recurrent Plasma Cell Myeloma
Multiple Myeloma
Recurrent Nervous System Lymphoma; Recurrent Primary Vitreoretinal DLBCL; Refractory Nervous System Lymphoma; Refractory Primary Vitreoretinal DLBCL
Pharmacology, Clinical; Healthy
Clinical Pharmacology, Healthy Volunteer Study
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Neurofibromatosis Type 1; Recurrent Childhood Brain Stem Glioma; Recurrent Childhood Visual Pathway Glioma; Recurrent Primary Central Nervous System Neoplasm; Refractory Primary Central Nervous System Neoplasm
Hereditary Hemorrhagic Telangiectasia; Idiopathic Vascular Ectasia
Plasma Cell Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma; Renal Impairment
Recurrent Plasma Cell Myeloma
Unspecified Adult Solid Tumor, Protocol Specific
Chronic Lymphocytic Leukemia; B-Cell Lymphoma
Multiple Myeloma
Multiple Myeloma
Healthy Volunteers
Multiple Myeloma
Waldenstrom's Macroglobulinemia
Relapsed and/or Refractory Multiple Myeloma
Multiple Myeloma in Relapse
Multiple Myeloma
Clinical Pharmacology, Healthy Volunteer Study
Multiple Myeloma in Relapse; Refractory Multiple Myeloma; Multiple Myeloma
Bioequivalence
Refractory Multiple Myeloma; Relapse Multiple Myeloma
Recurrent Waldenstrom Macroglobulinemia; Refractory Waldenstrom Macroglobulinemia
Multiple Myeloma
Light Chain Deposition Disease; Primary Systemic Amyloidosis
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Anemia, Sickle Cell
Healthy
Kaposi Sarcoma
Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Relapse/Refractory Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Phase 1
Early Phase 1
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Recruitment Status
Completed
Completed
Terminated
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Recruiting
Completed
Completed
Recruiting
Unknown status
Active, not recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Not yet recruiting
Active, not recruiting
Withdrawn
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Recruiting
Completed
Recruiting
Recruiting
Completed
Recruiting
Recruiting
Completed
Completed
Not yet recruiting
Active, not recruiting
Completed
Recruiting
Unknown status
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Terminated
Not yet recruiting
Recruiting
Completed
Not yet recruiting
Recruiting
Withdrawn
Completed
Completed
Completed
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Not yet recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Not yet recruiting
Terminated
Completed
Completed
Completed
Active, not recruiting
Withdrawn
Active, not recruiting
Completed
Recruiting
Completed
Active, not recruiting
Completed
Withdrawn
Active, not recruiting
Recruiting
Terminated
Recruiting
Completed
Unknown status
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Unknown status
Completed
Completed
Completed
Terminated
Terminated
Recruiting
Active, not recruiting
Terminated
Active, not recruiting
Completed
Unknown status
Recruiting
Active, not recruiting
Completed
Completed
Terminated
Terminated
Completed
Completed
Terminated
Active, not recruiting
Completed
Recruiting
Active, not recruiting
Recruiting
Completed
Completed
Terminated
Not yet recruiting
Active, not recruiting
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Suspended
Completed
Completed
Withdrawn
Active, not recruiting
Completed
Active, not recruiting
Terminated
Withdrawn
Terminated
Recruiting
Completed
Completed
Completed
Withdrawn
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Completed
Completed
Completed
Completed
Recruiting
Terminated
Terminated
No longer available
Active, not recruiting
Active, not recruiting
Approved for marketing
Completed
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Sirukumab
BA-003, CNTO-136
NDA/BLA
Glaxosmithkline Plc, Janssen Global Services Llc
Giant Cell Arteritis, Depressive Disorder, Major, Lupus Erythematosus, Cutaneous, Arthritis, Rheumatoid, Coronavirus Disease 2019 (COVID-19), Lupus Nephritis, Polymyalgia Rheumatica, Lupus Erythematosus, Systemic, Asthma
NCT Number
NCT01689532
NCT01856309
NCT01604343
NCT02899026
NCT02019472
NCT02531633
NCT01606761
NCT04380961
NCT02473289
NCT00718718
NCT02794519
NCT01273389
NCT01702740
NCT02079545
NCT01636557
NCT00844909
Intervention Type
Drug
Drug
Drug
Drug
Biological;Drug
Drug
Drug
Other;Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Drug
Indications
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Arthritis, Rheumatoid
Polymyalgia Rheumatica
Arthritis, Rheumatoid
Giant Cell Arteritis
Arthritis, Rheumatoid
Severe or Critical Confirmed Coronavirus Disease (COVID)-19
Depressive Disorder, Major
Arthritis, Rheumatoid
Asthma
Lupus Nephritis
Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
Healthy
Arthritis, Rheumatoid
Healthy
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1
Phase 1
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Withdrawn
Completed
Terminated
Completed
Recruiting
Completed
Completed
Withdrawn
Completed
Completed
Completed
Completed
Completed
PXL-01
PXL-01
Phase 3 Clinical
Promore Pharma
Tissue Adhesions, Post-surgical adhesions
NCT Number
NCT01022242
NCT00860080
Intervention Type
Drug
Drug
Indications
Surgical Adhesions
Post-surgery Adhesion Formation
Study Phase
Phase 2
Phase 1
Recruitment Status
Completed
Completed
Olokizumab
CDP-6038, Anti-IL6-UCB
Phase 3 Clinical
Ucb
Arthritis, Rheumatoid, Coronavirus Disease 2019 (COVID-19), Arthritis, Crohn Disease
NCT Number
NCT02760407
NCT02760433
NCT03120949
NCT02760368
NCT04452474
NCT01533714
NCT01635621
NCT01296711
NCT01242488
NCT01463059
NCT01009242
NCT04246762
NCT01262794
NCT01276119
Intervention Type
Drug
Drug
Drug
Drug
Drug
Biological
Drug
Biological
Other;Biological
Biological
Other;Biological;Drug
Drug
Biological
Other;Biological
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
COVID-19
Rheumatoid Arthritis
Crohn's Disease
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Arthritis; Rheumatoid Arthritis
Rheumatoid Arthritis
Healthy Volunteers
Pharmacokinetics
Study Phase
Phase 3
Phase 3
Phase 3
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Phase 1
Phase 1
Recruitment Status
Active, not recruiting
Active, not recruiting
Recruiting
Completed
Not yet recruiting
Completed
Withdrawn
Completed
Completed
Completed
Completed
Not yet recruiting
Completed
Completed
Clazakizumab
ALD-518, ALD518-003, BMS-645429, BMS-945429
Phase 3 Clinical
Alder Biopharmaceuticals
Anemia, Fatigue, Graft vs Host Disease, Arthritis, Rheumatoid, Rejection of organ transplantation, Arthritis, Psoriatic, Cachexia, Inflammation, Crohn Disease, Carcinoma, Non-Small-Cell Lung, Stomatitis
NCT Number
NCT03744910
NCT04351724
NCT04343989
NCT04659772
NCT00866970
NCT01373151
NCT04494724
NCT04348500
NCT04129931
NCT01490450
NCT04381052
NCT00867516
NCT02015520
NCT01403064
NCT04363502
NCT01545050
NCT03380962
NCT03380377
NCT01530256
Intervention Type
Biological;Drug
Other;Drug
Other;Drug
Drug
Biological
Biological;Drug
Drug
Drug
Other;Drug
Biological
Other;Drug
Biological
Drug
Biological;Drug
Drug
Biological
Drug
Drug
Biological
Indications
Antibody-mediated Rejection
COVID-19
COVID-19
Covid19; Respiratory Failure
NSCLC; Fatigue; Cachexia
Rheumatoid Arthritis
COVID-19 Infection
COVID19
Asthma
Arthritis, Psoriatic
COVID-19
Arthritis, Rheumatoid
Rheumatoid Arthritis
Oral Mucositis
Covid19
Crohn's Disease
Kidney Failure, Chronic; End-Stage Renal Disease; Transplant Glomerulopathy; Transplant;Failure,Kidney; Kidney Transplant Failure and Rejection; Antibody-mediated Rejection; Kidney Transplant; Complications
Antibody-mediated Rejection; Kidney Transplant; Complications; Transplant Glomerulopathy; Transplant Glomerulopathy - Late Form; Transplant Glomerulopathy - Early Form; Kidney Transplant Rejection
Acute GvHD
Study Phase
Phase 3
Phase 2/Phase 3
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Recruitment Status
Recruiting
Recruiting
Active, not recruiting
Enrolling by invitation
Completed
Completed
Recruiting
Active, not recruiting
Recruiting
Completed
Not yet recruiting
Completed
Completed
Terminated
Recruiting
Terminated
Active, not recruiting
Active, not recruiting
Terminated
CD24-Fc
CD24-Fc-IgG, CD24-Fc, HAS-CD24
Phase 3 Clinical
Oncoimmune
HIV Infections, Leukemia, Graft vs Host Disease, Coronavirus Disease 2019 (COVID-19), Myelodysplastic Syndromes, Dyslipidemias, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Melanoma
NCT Number
NCT04317040
NCT04095858
NCT03960541
NCT02663622
NCT04060407
NCT02650895
Intervention Type
Drug
Drug
Drug
Drug
Drug
Biological;Drug
Indications
Covid19
Hematopoietic Stem Cell Transplantation; Acute Graft Versus Host Disease; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes
HIV Infections; Dyslipidemias
Graft Versus Host Disease; Hematopoietic Stem Cell Transplantation; Leukemia
Metastatic Melanoma
Healthy Volunteers
Study Phase
Phase 3
Phase 3
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Completed
Gerilimzumab
GB-224, RYI-008, ARGX-109
Phase 2 Clinical
Argen-X
Arthritis, Rheumatoid
NCT Number
NCT02795299
NCT04179513
NCT04178070
Intervention Type
Drug
Biological
Other;Biological
Indications
Rheumatoid Arthritis
Rheumatoid Arthritis
Rheumatoid Arthritis
Study Phase
Phase 2
Phase 1
Phase 1
Recruitment Status
Withdrawn
Recruiting
Recruiting
Anti-interleukin-6 receptor monoclonal antibody (Biocad)
Phase 2 Clinical
Biocad
Autoimmune Diseases
PF-04236921
PF-4236921, PF-04236921
Phase 2 Clinical
Pfizer Pharmaceuticals Ltd (China)
Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Crohn Disease
NCT Number
NCT01345318
NCT01405196
NCT01287897
NCT00838565
NCT01166555
Intervention Type
Biological
Biological
Drug
Drug
Drug
Indications
Crohn's Disease
Lupus Erythematosus, Systemic
Crohn's Disease
Rheumatoid Arthritis
Healthy
Study Phase
Phase 2
Phase 2
Phase 2
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
Completed
DMT-210
DMT-200, DMT-210, DMT-220, SIG-990
Phase 2 Clinical
Signum Dermalogix
Rosacea, Dermatitis, Atopic
NCT Number
NCT03003104
NCT02949960
Intervention Type
Other;Drug
Drug
Indications
Acne Rosacea
Atopic Dermatitis
Study Phase
Phase 2
Phase 2
Recruitment Status
Completed
Completed
Ziltivekimab
COR-001
Phase 2 Clinical
Astrazeneca
Anemia, Inflammation, Renal Insufficiency, Chronic
NCT Number
NCT04626505
NCT03926117
NCT02868229
Intervention Type
Drug
Biological
Other;Drug
Indications
Chronic Kidney Disease; Inflammation; Cardiovascular Risk
Chronic Kidney Diseases; Inflammation
Anemia
Study Phase
Phase 2
Phase 2
Phase 1/Phase 2
Recruitment Status
Recruiting
Completed
Completed
Cis-urocanic acid
Cis-UCA, UCA-001, UCA-002
Phase 2 Clinical
Herantis Pharma
Dry Eye Syndromes, Urinary Bladder Neoplasms, Xerophthalmia, Dermatitis, Atopic
NCT Number
NCT02326090
NCT01320579
NCT01458847
NCT01476332
Intervention Type
Drug
Drug
Drug
Drug
Indications
Dry Eye Syndrome
Atopic Dermatitis
Non-muscle Invasive Bladder Cancer
Dry Eye
Study Phase
Phase 2
Phase 2
Phase 1
Phase 1
Recruitment Status
Completed
Completed
Completed
Completed
HL-2351
GX-P4, HL-2351, rhIL-1Ra-hyFc
Phase 2 Clinical
Genexine
Arthritis, Rheumatoid, Cryopyrin-Associated Periodic Syndromes
NCT Number
NCT02853084
NCT02175056
Intervention Type
Drug
Biological
Indications
Cryopyrin-Associated Periodic Syndromes (CAPS)
Healthy Volunteers
Study Phase
Phase 2
Phase 1
Recruitment Status
Terminated
Completed
MEDI-5117
WBP-216, MEDI-5117
Phase 1 Clinical
Wuxi Apptec Co Ltd, Medimmune
Arthritis, Rheumatoid
NCT Number
NCT01559103
Intervention Type
Biological
Indications
Rheumatoid Arthritis
Study Phase
Phase 1
Recruitment Status
Terminated
Tocilizumab biosimilar (Mycenax Biotech)
Phase 1 Clinical
Mycenax Biotech
Arthritis, Rheumatoid
EBI-031
EBI-031
Phase 1 Clinical
Sesen Bio
Diabetic macular oedema, Uveitis
NCT Number
NCT02842541
Intervention Type
Drug
Indications
Diabetic Macular Edema
Study Phase
Phase 1
Recruitment Status
Withdrawn
Wogonin
Phase 1 Clinical
Shandong Buchang Pharmaceuticals Co Ltd, Hefei Cosource Medicine Technology, Daewoong Pharmaceutical Co Ltd, China Pharmaceutical University
Respiratory Tract Infections, Neoplasms
FB-704A
FB-704, FB-704A
Phase 1 Clinical
Fountain Biopharma
Arthritis, Rheumatoid
NCT Number
NCT03890302
Intervention Type
Drug
Indications
Rheumatoid Arthritis
Study Phase
Phase 1
Recruitment Status
Completed
Y-25510
Y-25510
Pending
Mitsubishi Tanabe Pharma
Leukopenia, Thrombocytopenia
TA-383
TA-383
Pending
Mitsubishi Tanabe Pharma
Arthritis, Rheumatoid
YS-IL6
YS-IL6, YSIL-6, YSIL6-O-RA, YSIL6-T-PS
Pending
Y'S Therapeutics
Arthritis, Rheumatoid
Interleukin-6 receptor (Tosoh)
CD-126
Pending
Tosoh
Hematopoietic stem cell transplantation (HSCT)
FM-101 (Femta Pharmaceuticals)
FM-101
Pending
Femta Pharmaceutical
Arthritis, Rheumatoid, Multiple Myeloma, Crohn Disease
QR-449
QR-440, QR-443, QR-449
Pending
Prophase Labs
Pain, Metabolic Diseases, Cachexia
BLX-1002
BLX-1002
Pending
Orchid
Diabetes Mellitus, Type 2
Elsilimomab (Orphan Pharma international)
Pending
Aop Orphan Pharmaceuticals, Orphan Pharma International
Multiple Myeloma, Lymphoma
KOB-03
KOB-03
Pending
Rhinitis, Allergic
Atiprimod dihydrochloride
SK&F-106615-A2
Discontinued
Glaxosmithkline Plc, Genzyme Corp
Arthritis, Rheumatoid, Multiple Myeloma, Osteoarthritis, Carcinoma, Neuroendocrine
NCT Number
NCT00388063
NCT00663429
NCT00214838
NCT00086216
NCT00430014
Intervention Type
Drug
Drug
Drug
Drug
Drug
Indications
Neuroendocrine Carcinoma
Neuroendocrine Carcinoma
Advanced Cancer
Multiple Myeloma
Advanced Cancer
Study Phase
Phase 2
Phase 2
Phase 1/Phase 2
Phase 1/Phase 2
Phase 1
Recruitment Status
Completed
Completed
Unknown status
Completed
Terminated
Azacitidine/Lenalidomide
Discontinued
Celgene
Leukemia, Myeloid, Acute
Anti-IL-6 mAb (Vaccinex)
VX-30, OPR-003, mAb-1339
Discontinued
Vaccinex
Hematologic Neoplasms, Arthritis, Rheumatoid
ME-3738
ME-3738
Discontinued
Meiji Seika Pharma Co Ltd
Hepatitis C
AMG-220
C-326, AMG-220
Discontinued
Amgen Inc
Crohn Disease
NCT Number
NCT00353756
Intervention Type
Drug
Indications
Crohn's Disease
Study Phase
Phase 1
Recruitment Status
Unknown status